Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

Q17_VACTREL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q8726\|Q76\|Q675\|Q42\|Q43[5-9]\|Q20\|Q21\|Q22\|Q23\|Q24\|Q25\|Q26[1-4]\|Q39\|Q6[0-4]\|Q69[0-1]\|Q70[014]\|Q71 Hospital discharge: excluded ICD-10 — Q20.6, Q21.4, Q25.0, Q25.42, Q39.4, Q39.50, Q39.58, Q39.6 Cause of death: ICD-10 — Q8726\|Q76\|Q675\|Q42\|Q43[5-9]\|Q20\|Q21\|Q22\|Q23\|Q24\|Q25\|Q26[1-4]\|Q39\|Q6[0-4]\|Q69[0-1]\|Q70[014]\|Q71 2 out of 7 registries used, show all original rules.	7279
4. Check minimum number of events None	7279
5. Include endpoints None	7279
6. Filter based on genotype QC (FinnGen only)	7279

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF6v3

NAME	Q17_VACTREL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q8726\|Q76\|Q675\|Q42\|Q43[5-9]\|Q20\|Q21\|Q22\|Q23\|Q24\|Q25\|Q26[1-4]\|Q39\|Q6[0-4]\|Q69[0-1]\|Q70[014]\|Q71
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL	Q206\|Q214\|Q250\|Q2542\|Q39[4-6]
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q8726\|Q76\|Q675\|Q42\|Q43[5-9]\|Q20\|Q21\|Q22\|Q23\|Q24\|Q25\|Q26[1-4]\|Q39\|Q6[0-4]\|Q69[0-1]\|Q70[014]\|Q71
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly based on the number of shared cases.

Similar with more cases:

Congenital malformations, deformations and chromosomal abnormalities

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	82336	40259	41864
Only index persons	60093	29667	30426
Unadjusted period prevalence (%)
Whole population	1.16	1.15	1.17
Only index persons	1.13	1.09	1.16
Median age at first event (years)
Whole population	4.73	4.92	4.32
Only index persons	13.65	14.23	13.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7279	3822	3457
Unadjusted period prevalence (%)	1.41	1.30	1.52
Median age at first event (years)	43.32	39.02	48.08

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6133: Matched controls
60460

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q21.10

ICD-10 Finland

Persistent ostium secundum

6980.7

323.0

646

Q23.11

ICD-10 Finland

Bicuspid aortic valve

2444.3

323.0

1138

B01AA03

ATC

warfarin; systemic

4.5

323.0

1639

4539

Q21.19

ICD-10 Finland

Atrial septal defect NOS

+∞

323.0

377

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

2327.7

323.0

459

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

6.0

323.0

2026

4558

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

10.7

323.0

805

844

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

16.9

323.0

578

369

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

12.0

323.0

765

710

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

+∞

323.0

709

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

3866.3

323.0

379

Z94.0

ICD-10 Finland

Kidney transplant status

27.4

323.0

478

186

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

3438.2

323.0

648

FFC22

NOMESCO Finland

Percutaneous transluminal closure of ostium secundum type ASD

1688.2

323.0

315

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

12.6

323.0

1386

1367

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.1

323.0

2283

6261

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.8

317.2

868

1429

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

16.9

314.7

519

329

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

+∞

303.1

290

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

298.9

2983

15342

127

Kela drug reimbursment

Transplant complication

17.3

297.7

486

299

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

1519.9

297.5

289

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

13.4

295.2

536

428

A11CC03

ATC

alfacalcidol; systemic

13.9

288.7

516

397

Q25.1

ICD-10 Finland

Coarctation of aorta

+∞

287.3

275

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

32.4

285.3

383

124

I35.0

ICD-10 Finland

Aortic (valve) stenosis

7.9

276.7

674

927

Q62.10

ICD-10 Finland

Congenital unilateral occlusion of the pelvic ureteral junction

+∞

257.8

247

C03CA01

ATC

furosemide; systemic

3.1

243.9

1703

6761

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

241.7

1287

4178

XF620

NOMESCO Finland

Examination of circulation with color method

56.3

241.3

289

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

21.6

240.4

362

175

L04AA06

ATC

mycophenolic acid; systemic

13.6

240.0

432

335

A12AA04

ATC

calcium carbonate; oral

17.4

239.0

388

233

TK800

NOMESCO Finland

Hemodialysis

12.0

234.3

448

396

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

14.0

232.6

413

310

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

13.0

231.7

426

346

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

22.5

225.0

334

154

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

217.8

2089

9973

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

30.4

215.7

294

100

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.0

208.6

1410

5392

Q62.7

ICD-10 Finland

Congenital vesico-uretero-renal reflux

1925.6

205.1

199

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

30.5

202.0

275

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

198.4

1275

4685

Z49.1

ICD-10 Finland

Extracorporeal dialysis

15.5

194.4

330

221

ZXE20

NOMESCO Finland

More than three and less than five hours

3.2

193.4

1160

4052

Congenital heart failure surgery

949.3

190.6

187

XF404

NOMESCO Finland

Ambulatory ECG

4.0

189.7

856

2376

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.1

187.3

816

2193

201

Kela drug reimbursment

Chronic cardiac insufficiency

7.0

185.5

485

728

N18.0

ICD-10 Finland

End-stage renal disease

18.8

181.0

285

156

WX872

NOMESCO Finland

Intensive care

5.5

180.8

577

1121

N18.8

ICD-10 Finland

Other chronic renal failure

9.2

178.6

391

443

R4110

NOMESCO Finland

Physiotherapy

2.4

170.7

1835

9068

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.7

168.8

521

970

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

167.7

2501

14439

C07AB07

ATC

bisoprolol; oral

2.2

167.2

2563

14975

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

14.3

162.8

285

205

Z49.0

ICD-10 Finland

Preparatory care for dialysis

19.8

162.4

251

130

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

20.2

158.4

243

123

B03XA02

ATC

darbepoetin alfa; parenteral

12.0

156.9

298

257

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

16.0

156.8

262

168

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

155.0

2325

13324

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

12.1

148.3

280

238

Q61.99

ICD-10 Finland

Cystic kidney disease, unspecified

+∞

147.7

142

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

23.3

145.5

213

137

Kela drug reimbursment

Uraemia requiring dialysis

18.7

142.8

225

123

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

+∞

142.5

137

FFC00

NOMESCO Finland

Suture of ostium secundum type ASD

358.0

141.7

143

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

137.9

1082

4414

Q61.0

ICD-10 Finland

Congenital single renal cyst

+∞

136.2

131

XF402

NOMESCO Finland

ECG with work load test

3.2

133.9

808

2776

Z2221

NOMESCO Finland

Medical doctor

2.1

127.7

1863

10337

KA1AE

NOMESCO Finland

Kidney ultrasound examination

7.1

127.3

326

471

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.5

123.1

1136

5050

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

7.5

122.5

302

412

Q21.0

ICD-10 Finland

Ventricular septal defect

1195.1

121.7

119

L04AD01

ATC

ciclosporin; systemic

7.4

121.1

302

419

ZXE00

NOMESCO Finland

One hour or less

1.9

115.2

2489

15947

Q21.30

ICD-10 Finland

Tetralogy of Fallot

+∞

114.3

110

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.9

113.2

507

1369

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

112.6

738

2663

B05DA

ATC

Isotonic solutions

17.9

111.5

178

101

FM2CE

NOMESCO Finland

12.2

111.4

209

175

205

Kela drug reimbursment

Chronic hypertension

2.2

110.2

1377

7060

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

4.1

109.9

465

1193

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

109.1

1311

6598

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

11.4

108.2

209

186

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.3

106.4

594

1911

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

+∞

106.0

102

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

+∞

106.0

102

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

105.6

616

2047

Q21.9

ICD-10 Finland

Congenital malformation of cardiac septum, unspecified

1021.2

104.0

102

V03AE02

ATC

sevelamer; oral

21.6

103.0

154

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

11.2

102.2

199

180

Z49.2

ICD-10 Finland

Other dialysis

16.7

100.9

165

100

K83

ICPC

Heart valve disease NOS

12.9

100.4

183

144

74639

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

100.4

99.7

110

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

98.9

804

3296

UKC02

NOMESCO Finland

Cystoscopy

2.4

97.3

925

4125

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.8

97.2

447

1231

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

96.8

1343

7147

WX402

NOMESCO Finland

General anaesthesia

2.2

95.4

1146

5721

V03AE01

ATC

polystyrene sulfonate; oral

11.7

95.4

182

158

C01AA05

ATC

digoxin; systemic

3.7

93.9

442

1241

ZXD05

NOMESCO Finland

Urgent procedure

1.9

93.6

1901

11687

Catheterization and pressure measurement of the right side of the heart

32.8

93.3

124

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

7.4

92.7

230

316

FFC42

NOMESCO Finland

Percutaneous closure of patent foramen ovale

+∞

92.4

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

+∞

92.4

Z3226

NOMESCO Finland

Physiotherapist

2.1

90.8

1213

6329

B05DB

ATC

Hypertonic solutions

17.6

90.6

145

Z3231

NOMESCO Finland

Registered nurse

1.9

90.4

1744

10498

Q20.3

ICD-10 Finland

Discordant ventriculoarterial connection

+∞

89.3

WX892

NOMESCO Finland

Monitored bed care

3.0

88.9

569

2005

Q62.0

ICD-10 Finland

Congenital hydronephrosis

+∞

88.3

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

7.6

88.1

214

285

B01AB05

ATC

enoxaparin; parenteral

1.9

87.7

1596

9387

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

17.5

86.7

139

TFP20

NOMESCO Finland

Cardiodefibrillation

3.3

86.6

480

1529

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.1

86.6

361

910

74719

ICD-8 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta

180.0

85.9

B03XA01

ATC

erythropoietin; parenteral

13.8

85.7

151

110

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

29.9

85.3

116

Q25.0

ICD-10 Finland

Patent ductus arteriosus

30.1

84.0

114

196

Kela drug reimbursment

Paricalcitol and cinacalcet

20.8

83.4

126

Catheterization and pressure measurement of the left side of the heart

9.0

83.3

183

207

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.9

82.7

362

953

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

31.5

82.1

110

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

17.3

81.5

131

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

32.8

81.4

108

Q60.0

ICD-10 Finland

Renal agenesis, unilateral

+∞

81.0

XFE00

NOMESCO Finland

Epicardial ultrasonography

5.6

80.9

248

452

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

59.4

80.4

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

9.0

80.2

175

196

KAH41

NOMESCO Finland

Percutaneous endoscopic pyeloureteroplasty with division of ureteropelvic junction

66.4

80.1

PD5BD

NOMESCO Finland

Extensive CT of aorta

6.6

79.9

214

328

C07AB02

ATC

metoprolol; systemic

2.1

79.8

1026

5234

C08CA01

ATC

amlodipine; oral

1.8

79.0

1675

10322

R50.9

ICD-10 Finland

Fever, unspecified

2.1

78.4

972

4880

Q21.18

ICD-10 Finland

Other spedified atrial septal defect

+∞

77.9

XF640

NOMESCO Finland

5.3

77.5

249

480

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

4.1

77.1

316

783

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.5

76.9

388

1148

H02AB04

ATC

methylprednisolone; systemic

2.2

76.3

860

4132

Q61.1

ICD-10 Finland

Polycystic kidney, autosomal recessive

+∞

75.8

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

16.1

75.7

125

J01CA04

ATC

amoxicillin; systemic

1.8

75.5

5045

43309

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

15.5

74.6

125

KBV52

NOMESCO Finland

Cystoscopic injection therapy for vesicourethral reflux

371.6

74.5

C09AA02

ATC

enalapril; systemic

2.1

73.1

971

5003

TK820

NOMESCO Finland

Peritoneal dialysis

18.9

72.6

113

I50.9

ICD-10 Finland

Heart failure, unspecified

2.6

72.2

590

2402

7471A

ICD-9 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]

+∞

70.6

KAC00

NOMESCO Finland

Nephrectomy

23.2

70.1

102

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

69.9

465

1672

L04AA01

ATC

[U] ciclosporin; systemic

7.1

69.8

178

255

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

14.6

68.8

118

V03AE03

ATC

lanthanum carbonate; oral

23.6

68.4

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

15.8

67.4

112

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

66.9

589

2492

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

66.9

428

1501

AA1AD

NOMESCO Finland

CT of head and brain

1.9

66.5

1211

7014

XA800

NOMESCO Finland

Neuropsychological investigation

3.1

65.2

378

1239

C03DA01

ATC

spironolactone; oral

2.5

65.1

578

2456

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

63.3

2549

18616

Q62.5

ICD-10 Finland

Duplication of ureter

+∞

63.3

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

62.5

1237

7355

H05BX01

ATC

cinacalcet; oral

15.0

62.5

106

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

16.6

62.0

101

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.1

61.5

357

1170

C09AA05

ATC

ramipril; oral

1.9

60.6

1101

6349

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

3.8

60.5

268

711

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

107.9

59.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.4

59.4

186

348

K78

ICPC

Atrial fibrillation/flutter

2.9

59.2

384

1357

PA2AE

NOMESCO Finland

Ultrasound examination of brain artery

82.3

58.6

C07AG02

ATC

carvedilol; oral

3.1

58.3

340

1117

7455A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect

104.6

57.5

WX882

NOMESCO Finland

High dependency care

3.7

57.1

261

711

Q21.20

ICD-10 Finland

Atrial septal defect of primum type

+∞

57.1

Z2446

NOMESCO Finland

Social worker

2.4

56.6

540

2375

AF1

Surgery of congenital heart defect

285.2

56.0

C10AA05

ATC

atorvastatin; oral

1.6

55.1

1682

11323

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

13.3

54.5

XF622

NOMESCO Finland

Measurement of minute volume of heart

18.5

54.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

54.4

534

2382

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

14.3

54.0

Q61.5

ICD-10 Finland

Medullary cystic kidney

+∞

53.9

AN1

Coronary angiography

2.3

53.5

552

2520

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

53.3

392

1492

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

53.2

451

1864

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

53.0

365

1338

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

8.0

52.4

122

153

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

22.7

51.4

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.7

51.2

234

638

207

Kela drug reimbursment

Chronic arrhythmias

2.1

50.8

626

3093

ZX120

NOMESCO Finland

Intravenous

2.2

50.8

549

2560

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

26.2

50.8

C01BD01

ATC

amiodarone; systemic

4.2

50.7

200

478

J01MA02

ATC

ciprofloxacin; systemic

1.6

50.3

1898

13424

74629

ICD-8 Finland

Congenital anomalies of heart, Tetralogy of Fallot

253.8

49.8

Q21.21

ICD-10 Finland

Atrioventricular duct

+∞

49.8

KA1FN

NOMESCO Finland

Isotope renography

10.1

49.8

101

100

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

49.7

2470

18611

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

10.4

49.6

C08CA02

ATC

felodipine; oral

2.4

49.6

454

1952

3AC01

NOMESCO Finland

7.3

49.5

122

167

74642

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium secundum

41.1

49.4

KBV00

NOMESCO Finland

Insertion of stent into ureter

10.4

49.1

Q44.6

ICD-10 Finland

Cystic disease of liver

36.9

49.1

5255

FHL

Deep hypothermia (<20 °) with cardiopulmonary resuscitation

+∞

48.7

Q63.1

ICD-10 Finland

Lobulated, fused and horseshoe kidney

+∞

48.7

Q61.8

ICD-10 Finland

Other cystic kidney diseases

+∞

48.7

N13.7

ICD-10 Finland

Vesicoureteral-reflux-associated uropathy

29.4

48.0

N19

ICD-10 Finland

Unspecified kidney failure

4.2

47.7

191

463

Q64.4

ICD-10 Finland

Malformation of urachus

+∞

47.7

Q21.1

ICD-10 Finland

Atrial septal defect

+∞

47.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

47.3

870

4999

AB1

AVR mechanical

16.3

47.3

RD210

NOMESCO Finland

3.7

47.1

217

596

WX002

NOMESCO Finland

Sedation and analgesia

1.8

47.0

1005

6061

PD5BG

NOMESCO Finland

MRI examination of thoracal and abdominal aortta with high intensity magnet

60.8

47.0

WZC30

NOMESCO Finland

Teaching

1.9

46.8

721

3889

Q24.6

ICD-10 Finland

Congenital heart block

+∞

46.7

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

10.6

46.5

I37.0

ICD-10 Finland

Pulmonary valve stenosis

65.8

45.8

APK

ASD closure

+∞

45.6

Q76.30

ICD-10 Finland

Hemivertebra fusion or failure of segmentation with scoliosis

+∞

45.6

7454B

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]

121.7

45.5

R31

ICD-10 Finland

Unspecified haematuria

2.2

45.3

494

2308

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

28.9

44.9

B01AC04

ATC

clopidogrel; oral

2.0

44.7

665

3536

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

25.1

44.6

N02AX02

ATC

tramadol; systemic, rectal

1.5

44.0

2033

14953

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.8

43.9

195

519

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

63.3

43.9

Q43.8

ICD-10 Finland

Other specified congenital malformations of intestine

152.3

43.6

Q20.1

ICD-10 Finland

Double outlet right ventricle

+∞

43.6

204

Kela drug reimbursment

Leukemia lymphatica

3.4

43.4

219

647

Q64.2

ICD-10 Finland

Congenital posterior urethral valves

+∞

42.5

Q24.4

ICD-10 Finland

Congenital subaortic stenosis

+∞

42.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

42.4

1377

9306

R06.0

ICD-10 Finland

Dyspnoea

1.6

42.2

1194

7782

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

41.9

487

2340

1530

FHL

Urethrocystoscopy

5.3

41.7

131

247

75310

ICD-8 Finland

Congenital anomalies of urinary system, Ren polycysticus bilateralis

213.4

41.7

Z31.5

ICD-10 Finland

Genetic counselling

2.5

41.6

354

1464

APJ

PFO closure

+∞

41.5

Q60.3

ICD-10 Finland

Renal hypoplasia, unilateral

+∞

41.5

FFC50

NOMESCO Finland

Closure of ostium secundum type ASD using patch

+∞

41.5

C08CA13

ATC

lercanidipine; oral

2.0

41.2

583

3034

U14

ICPC

Kidney symptom/complaint

5.7

41.2

121

211

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.9

41.0

178

465

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

40.9

1254

8340

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

40.8

691

3843

Q20.48

ICD-10 Finland

Single ventricle

+∞

40.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

40.4

653

3572

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

53.0

40.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.9

39.9

170

437

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.6

39.8

301

1165

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.4

39.8

200

590

J01MA12

ATC

levofloxacin; systemic

1.7

39.7

879

5332

M04AA01

ATC

allopurinol; systemic

2.0

39.7

567

2961

J01EA01

ATC

trimethoprim; systemic

1.6

39.4

1194

7903

Q22.5

ICD-10 Finland

Ebstein anomaly

+∞

39.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

39.2

515

2604

K84

ICPC

Heart disease other

3.9

39.0

169

441

Q23.3

ICD-10 Finland

Congenital mitral insufficiency

384.5

38.9

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.9

38.9

131

268

PD5DG

NOMESCO Finland

Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

43.3

38.8

N02BE01

ATC

paracetamol; systemic, rectal

1.5

38.8

4644

40927

J01DB01

ATC

cefalexin; oral

1.5

38.6

4686

41384

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.1

38.0

155

383

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

20.2

37.9

ZXA00

NOMESCO Finland

Right side

1.6

37.7

1251

8462

N28.1

ICD-10 Finland

Cyst of kidney

5.5

37.6

114

207

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

12.5

37.5

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

37.5

1056

6851

Q23.4

ICD-10 Finland

Hypoplastic left heart syndrome

+∞

37.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.4

37.2

187

552

5937A

ICD-9 Finland

Other disorders of kidney and ureter, Vesicoureteric reflux

19.9

37.1

C09CA01

ATC

losartan; oral

1.6

37.0

1032

6674

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

36.9

809

4883

RS220

NOMESCO Finland

4.4

36.7

138

316

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

22.9

36.7

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

36.6

1622

11716

TK810

NOMESCO Finland

Hemofiltration

7.6

36.5

114

G04AC01

ATC

3.5

36.5

178

513

602

Kela drug reimbursment

Children's severe malnutrition

7.8

36.2

109

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

6.9

36.0

134

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

6.9

35.9

131

74663

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae pulmonalis

67.7

35.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

35.7

415

1989

Q25.3

ICD-10 Finland

Stenosis of aorta

183.4

35.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

35.4

385

1793

Q63.2

ICD-10 Finland

Ectopic kidney

+∞

35.2

A12BA01

ATC

potassium chloride; oral

3.1

35.1

197

631

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

35.0

208

693

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

35.0

344

1527

Z99.2

ICD-10 Finland

Dependence on renal dialysis

22.0

34.9

I49.5

ICD-10 Finland

Sick sinus syndrome

3.5

34.9

168

480

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

6.6

34.6

138

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

34.3

246

923

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

14.4

34.1

R4120

NOMESCO Finland

Occupational therapy

2.2

34.0

359

1649

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

33.8

426

2112

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

33.7

475

2466

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

7.6

33.4

103

I34.1

ICD-10 Finland

Mitral (valve) prolapse

3.4

33.2

170

509

Q25.48

ICD-10 Finland

Other congenital malformations of the aorta

+∞

33.2

Q62.18

ICD-10 Finland

Other specified atresia and stenosis of ureter

+∞

33.2

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

33.2

309

1338

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

15.8

33.0

J01XE01

ATC

nitrofurantoin; oral

4.4

32.9

122

276

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

25.4

32.9

FJF10

NOMESCO Finland

Replacement of pulmonary valve using biological prosthesis

324.3

32.7

I44.2

ICD-10 Finland

Atrioventricular block, complete

3.8

32.6

141

368

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

32.2

4328

46852

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

32.2

953

6238

Q62.2

ICD-10 Finland

Congenital megaloureter

+∞

32.1

Q21.3

ICD-10 Finland

Tetralogy of Fallot

+∞

32.1

Angiography of the heart and coronary arteries

2.5

31.4

255

1027

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

31.4

273

1139

Z94.1

ICD-10 Finland

Heart transplant status

13.8

31.2

WX610

NOMESCO Finland

Patient controlled analgesia

7.2

31.2

107

C02AC05

ATC

moxonidine; oral

2.7

31.1

222

830

FJF20

NOMESCO Finland

Replacement of pulmonary valve using homograft

+∞

31.1

Q76.48

ICD-10 Finland

Congenital anomalies of other vertebrae, not associated with scoliosis

+∞

31.1

Q24.8

ICD-10 Finland

Other specified congenital malformations of heart

+∞

31.1

Q26.3

ICD-10 Finland

Partial anomalous pulmonary venous connection

+∞

31.1

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

5.6

31.1

163

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

31.1

1884

14389

KBH20

NOMESCO Finland

Replantation of ureter

19.4

31.0

5205

FHL

ASD blockage, secondary defect

84.3

30.5

7454A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM NUD]

51.0

30.1

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

4.2

30.1

118

283

74619

ICD-8 Finland

Congenital anomalies of heart, Transposition of great vessels

+∞

30.1

FBE10

NOMESCO Finland

Expansion or reconstruction of pulmonary artery using patch

+∞

30.1

321

Kela drug reimbursment

Paricalcitol and cinacalcet

8.5

30.0

C07AA07

ATC

sotalol; systemic

3.0

29.9

178

595

XPX08

NOMESCO Finland

Intraoperative flow measurement

7.4

29.8

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

11.9

29.8

KAH40

NOMESCO Finland

Pyeloureteroplasty with division of ureteropelvic junction

32.2

29.7

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

9.9

29.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.0

29.7

180

609

5207

FHL

VSD closure

153.5

29.5

5253

FHL

Cardiac lung machine

7.7

29.4

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

19.8

29.3

I50.0

ICD-10 Finland

Congestive heart failure

2.4

29.3

263

1118

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.5

29.2

118

C09CA06

ATC

candesartan; oral

1.6

29.1

949

6343

74709

ICD-8 Finland

Other congenital anomalies of circulatory system, Patent ductus arteriosus

36.7

29.1

FBE35

NOMESCO Finland

Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent

+∞

29.0

Q25.6

ICD-10 Finland

Stenosis of pulmonary artery

+∞

29.0

Q22.0

ICD-10 Finland

Pulmonary valve atresia

+∞

29.0

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

9.8

29.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

28.9

445

2380

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

28.9

367

1825

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.0

28.7

172

577

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.8

28.7

125

330

FCA75

NOMESCO Finland

Valve-sparing repair of aortic root (David, Yacoub)

43.3

28.5

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

10.7

28.4

ZXA05

NOMESCO Finland

Left side

1.5

28.1

1109

7742

90492

NOMESCO Finland

35.7

28.1

Q24.0

ICD-10 Finland

Dextrocardia

+∞

28.0

Q61

ICD-10 Finland

Cystic kidney disease

+∞

28.0

R4190

NOMESCO Finland

Nutritional therapy

2.4

27.9

251

1068

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

27.7

1317

9554

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

16.8

27.6

7452A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Tetralogy of Fallot[TETRALOGIA FALLOT]

278.7

27.6

KAC10

NOMESCO Finland

Total nephrectomy with capsule

6.6

27.6

109

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

27.5

333

1621

I47.2

ICD-10 Finland

Ventricular tachycardia

3.6

27.1

125

346

C02EA02

ATC

2.8

27.0

182

659

7460C

ICD-9 Finland

Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITA CUM STENOSIS]

+∞

26.9

Q62.3

ICD-10 Finland

Other obstructive defects of renal pelvis and ureter

+∞

26.9

I50.1

ICD-10 Finland

Left ventricular failure

2.6

26.9

200

767

AP3

Catheterization of the right and left side of the heart

13.0

26.6

I97.0

ICD-10 Finland

Postcardiotomy syndrome

9.4

26.6

AP2

Catheterization of the right side of the heart

11.3

26.5

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

10.3

26.4

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

26.3

300

1426

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

3.7

26.3

118

320

C02CA01

ATC

prazosin; oral

4.7

26.2

194

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

14.5

26.2

A41.8

ICD-10 Finland

Other specified sepsis

4.2

26.1

100

235

RS224

NOMESCO Finland

6.7

26.0

100

7451A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[TRANSPOSITIO CORDIS COMPLETA]

+∞

25.9

Q25.40

ICD-10 Finland

Aortic hypoplasia

+∞

25.9

FHB50

NOMESCO Finland

Transatrial closure of VSD using patch

+∞

25.9

Q76.1

ICD-10 Finland

Klippel-Feil syndrome

+∞

25.9

L04AX01

ATC

azathioprine; systemic

2.2

25.8

264

1194

5AB14

NOMESCO Finland

12.7

25.8

AJ2

Reconstruction of the ascending aorta

20.9

25.8

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

25.7

222

924

74699

ICD-8 Finland

Congenital anomalies of heart, Unspecified anomalies of heart

39.6

25.6

R62.0

ICD-10 Finland

Delayed milestone

4.4

25.3

210

WX704

NOMESCO Finland

Intubation

1.9

25.3

363

1891

KC1JB

NOMESCO Finland

Miktiocystography with X-ray

32.7

25.3

WW502

NOMESCO Finland

Autotransfusion

6.6

25.3

100

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

25.3

314

1546

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

10.6

25.2

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

10.1

25.2

UJF32

NOMESCO Finland

Coloscopy

1.5

25.1

1117

7979

N25.0

ICD-10 Finland

Renal osteodystrophy

13.8

25.0

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

22.3

25.0

FM1CD

NOMESCO Finland

Very extensive CT of heart

9.9

24.9

Q25.41

ICD-10 Finland

Persistent right-sided aortic arch

+∞

24.9

AEX

Other pulmonary or pulmonary artery valve procedure

+∞

24.9

FDF05

NOMESCO Finland

Percutaneous transluminal occlusion of aorto-pulmonary collaterals

+∞

24.9

Q67.5

ICD-10 Finland

Congenital deformity of spine

+∞

24.9

R04.0

ICD-10 Finland

Epistaxis

2.0

24.9

326

1640

C08CA05

ATC

nifedipine; systemic

2.1

24.8

277

1304

Z2445

NOMESCO Finland

Psychologist

2.0

24.6

322

1621

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

23.1

24.5

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

12.5

24.5

R4150

NOMESCO Finland

Neuropsychological rehabilitation

5.0

24.5

160

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

24.4

217

919

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.3

24.4

239

1062

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

24.3

1805

14142

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.3

24.2

230

1007

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

24.1

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

24.0

123

371

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

24.0

163

593

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

23.9

400

2202

Q21.12

ICD-10 Finland

Defective sinus venosus

+∞

23.8

Q39.11

ICD-10 Finland

Atresia of oesophagus with broncho-oesophageal fistula

+∞

23.8

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

23.8

343

1794

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

23.7

535

3238

M10.9

ICD-10 Finland

Gout, unspecified

2.1

23.7

274

1312

FBE32

NOMESCO Finland

Percutaneous transluminal angioplasty of pulmonary artery

66.7

23.6

XF602

NOMESCO Finland

Bloodpressure monitoring

4.3

23.6

202

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.3

23.6

138

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

5.1

23.4

147

ZX199

NOMESCO Finland

Other rote

15.7

23.4

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.0

23.3

306

1544

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

4.9

23.2

157

B01AB10

ATC

tinzaparin; parenteral

2.0

23.2

311

1581

F83

ICD-10 Finland

Mixed specific developmental disorders

3.9

23.0

241

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

4.9

22.9

151

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.6

22.9

106

296

5910A

ICD-9 Finland

Hydronephrosis[HYDRONEPHROSIS]

13.8

22.8

Q25.78

ICD-10 Finland

Other congenital malformations of pulmonary artery

+∞

22.8

FAE10

NOMESCO Finland

Bidirectional anastomosis between superior vena cava and pulmonary artery

+∞

22.8

Q24.9

ICD-10 Finland

Congenital malformation of heart, unspecified

+∞

22.8

Q61.40

ICD-10 Finland

Renal dysplasia of a kidney (multicystic)

+∞

22.8

H05BX02

ATC

paricalcitol; systemic

18.3

22.8

WW200

NOMESCO Finland

Immunization

2.5

22.7

181

722

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

22.7

227

1016

TFP34

NOMESCO Finland

Electrophysiological investigation

2.6

22.6

170

657

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.1

22.6

130

426

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

22.6

506

3053

5513

FHL

Coarctation resection, plastic or bypass

227.5

22.5

74646

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium primum

118.7

22.4

I37.2

ICD-10 Finland

Pulmonary valve stenosis with insufficiency

118.7

22.4

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

22.6

22.4

KH1AD

NOMESCO Finland

CT of urinary organs

2.5

22.3

179

718

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

11.6

22.2

UGC02

NOMESCO Finland

Rigid bronchoscopy

7.6

22.2

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

22.1

803

5476

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

8.8

22.0

KH1EE

NOMESCO Finland

Urologic ultrasound examination

9.5

22.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

21.8

477

2859

Q21.29

ICD-10 Finland

Atrioventricular septal defect UNS

+∞

21.8

Q76.38

ICD-10 Finland

Congenital scoliosis due to other specified congenital bony malformation

+∞

21.8

Q21.81

ICD-10 Finland

Eisenmenger's syndrome

+∞

21.8

K90

ICPC

Stroke/cerebrovascular accident

3.1

21.7

124

404

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

7.4

21.5

7151

FHL

Kidney transplantation

18.2

21.5

K65.0

ICD-10 Finland

Acute peritonitis

4.5

21.5

171

R42

ICD-10 Finland

Dizziness and giddiness

1.5

21.5

910

6411

7463A

ICD-9 Finland

Other congenital anomalies of heart, Congenital stenosis of aortic valve[STENOSIS VALVULAE AORTAE CONGENITA]

113.8

21.4

K76.80

ICD-10 Finland

Hepatic cyst

6.3

21.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

21.3

2844

24165

XKD00

NOMESCO Finland

Uroflowmetry

1.6

21.3

645

4216

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

6.9

21.3

A02BC02

ATC

pantoprazole; systemic

1.3

21.1

3051

26196

UKB02

NOMESCO Finland

Retrograde ureteroscopy

4.6

21.1

161

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

21.1

409

2365

K99

ICPC

Cardiovascular disease other

2.9

21.0

127

431

KBV10

NOMESCO Finland

Removal of stent from ureter

5.1

20.9

128

A02BC01

ATC

omeprazole; systemic

1.4

20.9

1216

9096

Aortic Valve Replacement (AVR)

13.2

20.7

Q26.1

ICD-10 Finland

Persistent left superior vena cava

+∞

20.7

Q21.80

ICD-10 Finland

Communication from left ventricle to right atrium

+∞

20.7

Q23.8

ICD-10 Finland

Other congenital malformations of aortic and mitral valves

+∞

20.7

Q63.9

ICD-10 Finland

Congenital malformation of kidney, unspecified

+∞

20.7

FDA00

NOMESCO Finland

Aortoplasty and aorto-pulmonary shunt for HLHS

+∞

20.7

Q60.4

ICD-10 Finland

Renal hypoplasia, bilateral

+∞

20.7

N28.8

ICD-10 Finland

Other specified disorders of kidney and ureter

11.4

20.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

20.5

312

1664

Q62.11

ICD-10 Finland

Congenital bilateral occlusion of the pelvic ureteral junction

207.7

20.5

Q21.32

ICD-10 Finland

Pulmonary atresia with Fallot ventricular septal defect

207.7

20.5

FPF20

NOMESCO Finland

Implantation of epicardial pacemaker with atrial and ventricular electrodes

108.8

20.4

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

20.4

439

2619

RS221

NOMESCO Finland

3.1

20.4

113

363

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

15.6

20.3

GD1LA

NOMESCO Finland

4.1

20.3

195

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.4

20.3

176

738

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

2.8

20.3

132

469

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

20.2

296

1556

AB2

AVR bio, stent

6.2

20.1

M10.3

ICD-10 Finland

Gout due to impairment of renal function

9.9

20.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

20.0

860

6073

L04AA05

ATC

[U] tacrolimus; systemic

17.1

19.8

7AX01

NOMESCO Finland

18.6

19.7

Q61.48

ICD-10 Finland

Nonspecified renal dysplasia

+∞

19.7

Q24.3

ICD-10 Finland

Pulmonary infundibular stenosis

+∞

19.7

FFC32

NOMESCO Finland

Percutaneous transluminal closure of sinus venosus type ASD

+∞

19.7

Q76.9

ICD-10 Finland

Congenital malformation of bony thorax, unspecified

+∞

19.7

74673

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae aortae

35.3

19.7

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026250) Tacrolimus [Mass/volume] in Blood

407

300

13.85

307.65

37.9

37.6

ug/l

7.0

7.2

0.81

376

282

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

898

2007

4.80

307.65

5.0

3.6

92.2

93.0

0.42

864

1892

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2050

7245

3.42

307.65

16.6

6.8

mmol/l

1.2

1.1

13.06

2005

6806

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1261

3685

3.80

307.65

10.4

4.3

ng/l

129.0

82.5

28.67

1178

3260

(3020779) Urea [Moles/volume] in Serum or Plasma

1851

4765

4.71

307.65

16.5

8.8

mmol/l

10.0

8.6

13.45

1821

4568

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2340

7825

3.80

307.65

3.7

2.6

30.5

29.9

5.00

2297

7605

(3032080) INR in Blood by Coagulation assay

3864

19129

3.05

307.65

17.3

7.9

inr

1.5

1.2

46.56

1077

5746

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

889

1913

4.99

307.65

9.4

8.9

mg/l

1.6

1.3

18.56

866

1809

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1193

3544

3.70

307.65

4.0

3.0

ng/l

216.0

175.3

2.31

1092

3152

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3008

11889

3.48

307.65

4.6

3.0

ng/l

1582.8

1258.3

2.21

2756

9947

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1944

8222

2.76

286.27

6.4

4.4

mmol/l

0.8

0.32

1878

7721

(3033658) Prothrombin time (PT) actual/Normal

2742

13743

2.50

284.37

6.5

4.4

85.2

91.2

23.26

2696

13422

(3000991) Gas panel - Venous blood

1416

5064

3.12

283.25

14.6

9.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

330

328

10.15

282.93

29.0

27.9

ug/l

109.0

123.6

2.31

282

277

(3042733) HLA Ab [Presence] in Serum

278

217

12.85

279.44

5.7

4.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

676

1478

4.78

275.74

7.7

4.3

u/ml

0.3

1.10

397

842

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2584

12808

2.48

272.09

2.8

2.4

—

(3012544) pH of Venous blood

1490

5703

2.92

262.49

9.9

5.5

7.4

0.40

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1678

6899

2.76

257.88

5.7

2.5

22.6

23.4

1.66

1516

6015

(3036489) Thrombin time

840

2292

3.88

255.45

3.4

3.1

22.1

21.7

0.99

740

2011

(3044640) Blood type and Crossmatch panel - Blood

3029

16692

2.30

244.56

3.0

2.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

221

146

15.07

244.18

5.9

7.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1077

3563

3.26

243.20

10.2

6.3

mmol/l

23.5

24.0

7.13

1025

3300

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1730

7436

2.64

241.72

5.5

2.5

g/l

2.3

2.4

9.96

1665

6933

(3022948) Iron [Moles/volume] in Serum or Plasma

1830

8116

2.58

239.51

5.4

2.5

umol/l

12.7

13.7

7.36

1760

7589

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1420

5567

2.83

237.12

9.9

5.5

kpa

5.8

0.04

1396

5403

(3002032) Base excess in Venous blood by calculation

1414

5553

2.82

235.18

10.0

5.5

mmol/l

1.0

1.7

13.74

1204

4477

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

715

1867

4.00

230.52

3.4

3.5

172.0

179.3

1.42

701

1786

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

504

1000

5.17

229.64

6.2

4.6

u/ml

1118.3

656.6

0.21

(40768446) Kidney Pathology biopsy report

266

269

9.89

224.91

2.3

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

569

1289

4.55

221.04

10.4

6.6

iu/ml

783.8

1881.1

0.41

136

181

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3758

23341

2.16

217.61

16.1

6.6

mmol/l

1.2

6.34

3580

21363

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3989

25591

2.13

209.31

17.4

7.2

mmol/l

1.2

12.60

3519

21888

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3950

25255

2.13

209.01

4.6

4.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

692

1925

3.74

203.10

4.8

3.8

g/l

3.2

3.4

4.69

671

1839

(3024354) Oxygen [Partial pressure] in Venous blood

1214

4747

2.77

201.09

7.9

5.3

kpa

5.4

4.8

11.97

1192

4601

(3000850) Epithelial cells [#/volume] in Urine

2162

11140

2.25

196.20

4.9

2.6

e6/l

4.8

5.9

3.44

1963

9741

(3013826) Glucose [Moles/volume] in Serum or Plasma

4579

31444

2.11

194.44

9.0

4.9

mmol/l

6.4

6.6

8.31

4365

29133

(3022217) INR in Platelet poor plasma by Coagulation assay

1325

5566

2.60

189.42

43.0

20.6

inr

1.8

1.3

9.50

119

845

(3014576) Chloride [Moles/volume] in Serum or Plasma

1417

6150

2.53

189.19

9.8

7.9

mmol/l

105.0

104.5

2.93

1395

6022

(3024928) Oxygen saturation in Venous blood

488

1112

4.48

187.62

7.1

6.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1869

9233

2.29

186.22

4.5

3.4

ng/l

1296.3

532.6

5.02

1513

6524

(3002582) Erythrocytes [#/volume] in Urine

2809

16320

2.09

185.20

6.1

3.2

e6/l

112.0

82.0

0.24

2364

12365

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1018

3779

2.87

185.04

2.3

ug/l

15.0

7.4

13.20

944

3350

(3023368) Bacteria identified in Blood by Culture

2384

13182

2.12

177.73

6.3

4.3

—

(3030467) Casts [#/volume] in Urine by Automated count

2620

15011

2.08

177.63

5.8

3.1

e6/l

0.3

0.4

0.98

2170

11151

(36304419) Bacteria [Presence] in Urine

2575

14809

2.06

171.44

5.6

3.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3417

21748

1.99

170.63

9.5

5.2

g/l

36.0

36.2

1.12

3250

20300

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1265

5608

2.43

158.87

3.4

4.7

u/l

255.3

246.6

0.96

1224

5325

(3018095) Leukocytes [#/volume] in Urine

3087

19368

1.95

156.68

7.1

3.7

e6/l

65.3

81.9

0.70

2458

13342

(3026782) Osmolality of Urine

1952

10452

2.10

154.63

4.9

2.7

mosm/kgh2o

529.0

560.0

8.06

1752

8911

(3018418) pH of Serum or Plasma

2482

14552

1.99

152.65

10.5

4.0

7.4

3.55

545

2781

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

153

121

12.48

152.21

8.2

8.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2501

14747

1.98

150.95

2.6

2.2

u/l

250.8

238.4

0.27

2405

13930

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

509

1401

3.71

150.65

2.5

1.6

u/ml

111.9

108.0

0.30

105

227

(3014111) Lactate [Moles/volume] in Serum or Plasma

1082

4591

2.51

148.73

12.4

8.2

mmol/l

1.2

1.4

4.82

1044

4376

(3038071) Oxygen [Partial pressure] in Mixed venous blood

144

107

13.26

148.69

7.3

8.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

529

1510

3.58

148.25

2.5

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

997

4099

2.57

146.31

9.9

5.3

mmol/l

1.4

1.3

0.15

735

2979

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

525

1507

3.56

145.84

2.4

1.6

u/ml

10.1

24.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

646

2116

3.15

145.15

2.0

1.8

g/l

1.4

1.5

1.44

546

1837

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3865

26553

1.88

144.41

7.2

6.3

umol/l

13.8

12.0

6.84

3687

25100

(3009343) pH of Capillary blood

1009

4204

2.54

143.85

10.0

5.3

7.4

2.23

136

393

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1014

4247

2.52

142.92

10.0

5.3

kpa

5.0

5.1

1.99

987

3994

(3024932) HLA-DR beta [Type]

195

241

8.02

140.78

1.0

1.1

—

(3024471) HLA-A [Type]

196

245

7.93

140.17

1.0

—

(3044889) 12 lead EKG panel

4835

35969

1.91

137.61

4.9

3.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

958

3987

2.53

136.48

3.6

2.6

ml/min/173m2

51.7

71.4

29.69

410

1485

(3028626) Oxygen [Partial pressure] in Capillary blood

670

2327

2.97

135.66

10.6

6.3

kpa

9.2

0.20

656

2199

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

337

738

4.58

135.64

1.2

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1715

9160

2.06

133.98

4.2

2.8

e6/l

0.8

1.1

2.65

1117

5100

(3027801) Oxygen [Partial pressure] in Arterial blood

1166

5374

2.31

132.06

12.4

7.8

kpa

13.3

12.8

2.15

1129

5122

(42870588) Differential panel, method unspecified - Blood

3051

19836

1.84

131.98

7.7

6.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1165

5375

2.31

131.59

12.4

7.8

kpa

5.2

5.1

2.76

1128

5123

(3027945) Reticulocytes/100 erythrocytes in Blood

1216

5715

2.27

131.45

4.0

3.3

1.7

1.03

1142

5128

(3003396) Base excess in Arterial blood by calculation

1159

5365

2.30

129.76

12.5

7.8

mmol/l

0.5

0.9

2.63

964

4148

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

342

787

4.36

129.24

2.4

2.5

—

(3016502) Oxygen saturation in Arterial blood

1064

4787

2.35

127.10

13.2

8.3

96.0

95.8

0.56

1036

4597

(3004119) Hemoglobin [Mass/volume] in Venous blood

761

2972

2.65

122.96

7.6

4.6

g/l

121.2

130.7

21.61

744

2895

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

515

1641

3.19

120.66

1.9

1.4

u/ml

259.7

238.1

0.97

376

942

(4306422)

360

907

3.99

120.47

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

185

260

7.04

119.36

1.2

—

(3001604) Monocytes [#/volume] in Blood

4022

28988

1.77

118.29

8.0

6.5

e9/l

0.6

1.10

3536

25044

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

349

872

4.02

118.12

1.1

113.0

114.7

0.41

335

792

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1601

8679

2.01

118.09

4.5

2.9

e6/l

2.6

0.04

990

4635

(3006315) Basophils [#/volume] in Blood

4031

29082

1.77

118.03

8.0

6.5

e9/l

0.0

4.42

3548

25128

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

179

251

7.05

115.72

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

359

934

3.86

114.81

1.3

u/ml

4.3

4.7

0.19

160

427

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

40.80

114.23

6.9

9.0

—

(3011648) Oxygen content in Venous blood

245

474

5.14

114.13

5.5

9.6

11.5

11.3

0.34

245

474

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

264

545

4.83

114.03

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

516

1720

3.05

111.77

1.8

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

972

4433

2.30

111.54

12.7

8.7

g/l

116.6

123.2

18.32

942

4268

(3019198) Lymphocytes [#/volume] in Blood

4098

29992

1.74

111.21

8.1

6.5

e9/l

1.8

2.0

13.47

3651

26485

(3013115) Eosinophils [#/volume] in Blood

4109

30100

1.74

111.09

8.4

6.8

e9/l

0.2

1.09

3661

26446

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1494

8075

2.00

110.21

2.1

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

616

2289

2.75

109.30

6.4

4.5

1.2

1.3

1.19

616

2273

(3022096) Basophils/100 leukocytes in Blood

3711

26513

1.73

108.90

8.4

6.7

0.6

0.7

2.71

3573

24892

(3019550) Sodium [Moles/volume] in Serum or Plasma

6617

56635

2.53

108.19

28.1

14.0

mmol/l

139.5

139.6

6.23

6539

55145

(3019069) Monocytes/100 leukocytes in Blood

3812

27482

1.72

107.83

8.6

6.9

8.7

8.5

4.37

3673

25896

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2720

17877

1.76

107.12

4.1

3.3

ng/l

55.1

79.0

0.38

1890

10970

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

602

2234

2.75

107.02

6.5

4.5

0.7

0.6

2.26

594

2147

(3022313) Gas panel - Capillary blood

774

3248

2.46

107.02

10.7

5.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

662

2579

2.63

106.94

16.7

10.8

—

(3006504) Eosinophils/100 leukocytes in Blood

3788

27317

1.72

106.51

8.4

6.6

2.9

0.21

3637

25609

(3023103) Potassium [Moles/volume] in Serum or Plasma

6621

56810

2.51

105.31

28.6

14.1

mmol/l

4.0

32.66

6536

55181

(3014007) Fractional oxyhemoglobin in Arterial blood

733

3026

2.49

104.91

14.2

10.0

94.3

94.1

0.23

733

3014

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

153

201

7.50

104.80

3.2

2.8

—

(3042936) Bacteria identified in Isolate by Culture

1371

7304

2.01

104.79

2.4

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

346

953

3.64

101.74

1.3

u/ml

3.3

4.1

0.38

128

334

(3021589) Normoblasts [#/volume] in Blood

3618

26024

1.69

100.39

12.7

9.4

e9/l

0.0

0.20

2953

21113

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1109

5548

2.10

100.27

2.1

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

3882

28492

1.69

99.41

8.4

6.6

27.7

29.7

24.12

3727

26742

(3013650) Neutrophils [#/volume] in Blood by Automated count

4368

33102

1.70

98.88

10.3

9.4

e9/l

4.1

4.0

1.30

3869

28759

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5123

40594

1.76

98.11

10.4

7.2

u/l

83.8

80.4

3.93

4936

38341

(3018010) Neutrophils/100 leukocytes in Blood

3831

28083

1.68

97.98

8.1

6.4

57.2

55.6

14.86

3691

26455

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

329

901

3.65

97.53

8.4

3.4

—

(3023520) Reticulocytes [#/volume] in Blood

894

4157

2.23

97.14

3.6

3.0

e9/l

67.9

69.9

0.81

636

3037

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1106

5597

2.08

96.71

2.1

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

337

948

3.56

95.96

1.1

—

(40758558) Short blood count panel - Blood

2287

14773

1.73

92.58

7.4

7.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

625

2542

2.51

91.90

14.3

10.5

mmol/l

23.8

24.2

2.61

612

2392

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

272

680

3.98

91.82

8.4

7.0

mg/l

10.9

11.3

0.49

245

630

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

710

3065

2.38

91.61

11.2

5.6

mmol/l

24.6

24.3

1.71

693

2940

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2106

13364

1.74

90.45

2.7

2.3

mg/l

3.1

2.8

4.04

1872

11533

(3037467) Urinalysis macro (dipstick) panel - Urine

4809

37863

1.68

89.51

6.9

4.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

12.70

87.84

7.1

5.5

ug/min

35.9

48.7

0.72

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

259

653

3.94

86.39

1.1

93.8

96.0

0.59

253

613

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3496

25580

1.62

85.40

4.6

2.8

ug/l

138.7

109.7

1.27

3329

23954

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

984

4982

2.05

85.15

3.7

3.2

—

(4268621)

252

648

3.86

81.75

2.5

2.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2032

13060

1.70

81.74

4.6

2.7

umol/l

3030.3

3949.1

0.56

1874

11527

(3031040) Bacteria [#/volume] in Urine by Automated count

4548

35727

1.62

81.00

6.3

4.1

e6/l

972.9

1338.9

0.26

443

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

101

9.40

80.07

3.4

3.0

mg/l

49.1

25.9

—

(3026008) Bacteria identified in Urine by Culture

2208

14617

1.66

78.84

3.6

2.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

382

1322

2.90

76.92

6.0

4.2

mmol/l

22.8

24.6

13.37

359

1161

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6575

57622

2.14

75.58

23.0

12.5

mg/l

25.6

22.8

10.10

5566

44283

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

402

1493

2.70

70.76

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2609

18412

1.58

69.66

4.1

3.4

u/l

32.8

34.7

0.68

2514

17521

(3048929) Epstein Barr virus Ab [Presence] in Serum

641

2973

2.19

69.03

1.8

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

2363

16347

1.59

68.42

5.3

3.4

mmol/l

6.9

8.1

31.13

2144

14075

(3035350) Ketones [Presence] in Urine by Test strip

3540

26956

1.53

65.92

5.5

3.4

estimate

0.0

1.34

734

4987

(3012516) Albumin [Mass/volume] in Urine

2030

13653

1.61

65.58

5.4

3.3

mg/l

320.6

344.1

0.10

1535

8902

(3003694) ABO and Rh group [Type] in Blood

2450

17264

1.56

64.61

1.6

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

3532

26992

1.52

63.90

7.4

4.6

estimate

0.0

0.80

748

5173

(3014148) Varicella zoster virus Ab [Titer] in Serum

297

997

2.96

63.08

1.2

—

(3021901) Oxygen saturation in Capillary blood

281

917

3.04

62.73

5.1

3.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2091

14288

1.58

62.61

6.3

4.1

mg/mmol

21.9

9.8

1.03

1570

9361

(3009261) Glucose [Presence] in Urine by Test strip

3549

27257

1.51

61.96

5.5

3.4

estimate

0.0

0.06

741

4984

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

9.06

61.93

2.8

2.1

ug/g

165.6

165.3

0.00

(3002385) Erythrocyte distribution width [Ratio]

5793

49540

1.66

61.78

27.2

15.3

13.6

13.5

8.50

5731

48498

(1616796) Gas panel - Central venous blood

329

1183

2.77

61.56

6.3

3.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2981

22147

1.51

60.54

3.4

2.3

nmol/l

76.0

74.3

2.91

2786

20327

(3006576) Bicarbonate [Moles/volume] in Blood

107

175

5.99

59.69

8.9

6.9

mmol/l

25.0

24.8

0.20

161

(3011397) Hemoglobin [Presence] in Urine by Test strip

1891

12814

1.58

57.83

5.2

3.4

—

(40761511) CBC panel - Blood by Automated count

6699

60063

2.07

57.12

21.3

11.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2291

16247

1.53

56.99

3.3

2.6

u/l

61.7

57.1

3.94

2149

15054

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1766

11829

1.59

56.55

2.8

2.0

mg/l

1.5

1.1

1.67

1332

8782

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

300

1081

2.76

55.88

1.2

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

695

3599

1.96

55.16

1.9

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

17.52

53.94

5.8

5.6

—

(3034426) Prothrombin time (PT)

112

217

5.06

52.10

1.2

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

404

1750

2.31

50.98

3.2

2.5

ug/l

482.0

624.5

0.45

384

1640

(3037121) Protein [Mass/volume] in Urine

435

1950

2.23

50.58

6.1

4.1

g/l

0.3

0.4

1.38

300

964

(3019060) Gas panel - Arterial blood

591

3007

1.98

49.16

8.8

4.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

881

5108

1.76

48.51

3.1

2.8

g/l

0.2

0.53

842

4794

(3006184) Hemoglobin [Mass/volume] in Capillary blood

298

1153

2.56

48.16

3.0

2.2

g/l

131.0

131.9

0.25

244

853

(3015377) Calcium [Moles/volume] in Serum or Plasma

2290

16692

1.48

47.96

4.5

3.2

mmol/l

2.4

0.49

2061

14784

(3007853) Bacteria identified in Skin by Aerobe culture

1073

6592

1.67

47.80

2.0

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

475

2261

2.11

47.40

7.4

3.7

mmol/l

24.5

25.2

4.59

463

2181

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

7.60

46.84

7.8

8.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

561

2866

1.97

46.04

1.9

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

563

2882

1.97

45.93

12.5

6.9

mmol/l

24.5

24.4

0.24

525

2675

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1021

6262

1.67

45.61

4.4

3.5

umol/l

8.2

7.5

0.59

911

5411

(3018738) Hemoglobin F/Hemoglobin.total in Blood

7.40

45.10

4.1

3.7

4.3

4.7

0.06

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

100

6.83

44.53

6.7

6.4

mg/l

2.0

2.5

1.21

(3052851) Hemolysis interference index of Serum or Plasma

364

1602

2.26

44.17

4.1

3.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4808

40539

1.44

44.00

4.7

3.9

mm/h

11.6

10.5

6.02

4546

37759

(40767503) Oxygen content in Capillary blood by calculation

279

1093

2.53

43.93

3.6

2.5

16.8

0.06

195

545

(3051651) Icteric interference index of Serum or Plasma

143

383

3.66

43.79

4.9

4.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

391

1782

2.19

43.56

2.7

2.0

ug/l

2.8

2.3

0.35

357

1593

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

326

1377

2.35

43.54

1.9

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

329

1396

2.34

43.49

1.8

—

(3013512) EKG study

1889

13491

1.48

42.86

5.0

3.5

—

(3025315) Body weight

11.52

42.84

4.0

3.4

—

(3049717) Cytology report of Urine Cyto stain

354

1561

2.26

42.75

2.4

2.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.69

42.43

4.5

5.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1251

8197

1.58

42.42

2.6

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

112

268

4.09

40.19

5.0

6.1

mg/l

1329.6

65.1

0.51

206

(3020630) Protein [Mass/volume] in Serum or Plasma

659

3705

1.79

39.95

2.2

2.7

g/l

64.7

66.6

7.62

618

3424

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

228

851

2.64

39.64

1.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.50

39.48

4.2

5.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

686

3931

1.76

38.93

7.6

3.9

mmol/l

1.2

0.11

649

3436

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

289

1218

2.35

38.79

1.5

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5766

50746

1.49

38.73

20.4

11.3

ml/min/173m2

80.6

87.7

60.22

4984

41024

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

288

1218

2.34

38.35

1.5

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

489

2535

1.93

38.28

5.1

2.8

e6/l

0.1

0.2

5.32

476

2467

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

319

1420

2.23

37.64

1.5

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

169

559

2.97

36.89

4.7

3.7

—

(3027315) Oxygen [Partial pressure] in Blood

280

1196

2.32

36.44

6.4

4.5

kpa

8.9

8.8

0.54

274

1175

(3012501) Base excess in Blood by calculation

276

1190

2.29

35.15

6.5

4.4

mmol/l

1.9

2.4

3.18

167

787

(3013290) Carbon dioxide [Partial pressure] in Blood

276

1191

2.29

35.08

6.5

4.4

kpa

4.9

5.0

2.38

271

1170

(44806118)

204

766

2.62

35.07

1.8

1.7

—

(44790048)

204

766

2.62

35.07

1.8

1.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

112

298

3.68

34.70

1.2

1.1

u/ml

15.8

17.2

—

(44790049)

203

766

2.61

34.56

1.8

1.7

—

(44790047)

203

766

2.61

34.56

1.8

1.7

—

(40761535) Cells panel - Urine sediment

683

4049

1.70

34.14

6.0

3.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

246

1022

2.38

34.12

1.7

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

234

963

2.40

33.15

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

124

364

3.34

33.10

1.1

1.2

ratio

1.1

1.0

1.45

136

(3016750) Collection duration of Urine

105

283

3.63

31.95

3.8

2.1

min

506.8

492.1

0.95

211

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

811

5123

1.60

31.44

3.1

2.5

u/l

43.9

46.0

0.08

727

4406

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

101

269

3.67

31.28

1.0

1.1

96.3

95.1

0.15

211

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

187

714

2.57

31.11

1.7

1.8

—

(3010421) pH of Blood

298

1398

2.11

30.80

6.7

4.4

7.4

3.60

272

1170

(3029937) Albumin [Presence] in Urine by Test strip

1901

14353

1.38

29.61

6.1

3.7

estimate

0.0

0.36

700

4971

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

115

346

3.25

29.54

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1557

11399

1.41

29.03

2.5

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.97

28.83

3.7

2.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1499

10914

1.41

28.81

1.6

1.5

nmol/l

20.2

20.1

0.09

1346

9446

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

353

1837

1.90

27.23

10.0

5.4

1.7

0.18

328

1703

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.07

26.37

8.1

7.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1161

8189

1.44

26.34

1.8

1.7

nmol/l

1250.9

1159.8

2.50

922

6239

(3020891) Body temperature

363

1934

1.86

26.04

7.6

4.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

504

2966

1.69

25.70

1.7

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

961

2.21

25.57

1.6

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.57

24.64

1.4

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

343

1829

1.85

24.54

10.2

5.4

0.9

0.16

318

1699

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2570

20795

1.30

23.85

5.6

3.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

7.23

23.57

12.5

10.6

e6/l

181.5

128.0

0.48

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

398

2249

1.75

23.48

2.1

1.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

199

3.67

23.45

4.4

7.7

g/mol

717.4

105.0

0.46

188

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

165

680

2.38

23.39

1.5

—

(3047181) Lactate [Moles/volume] in Blood

292

1506

1.91

23.16

11.5

6.1

mmol/l

1.2

1.3

1.65

258

1303

(3000494) Fungus identified in Specimen by Culture

919

6343

1.46

23.16

1.7

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

163

675

2.37

22.87

3.0

3.1

nmol/l

0.8

0.05

129

507

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

183

797

2.25

22.84

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.55

22.43

3.2

5.0

—

(3004775) Volume in Urine collected for unspecified duration

109

374

2.85

22.42

3.6

2.2

802.4

620.4

2.70

254

(3009445) Proteinase 3 Ab [Units/volume] in Serum

397

2277

1.73

22.22

1.3

1.6

u/ml

7.5

14.3

—

(3002256) Pathology report gross observation

929

6483

1.44

22.02

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

256

1292

1.95

21.67

3.0

3.2

umol/l

31.9

35.5

1.89

231

1129

(3043409) Potassium [Moles/volume] in Arterial blood

270

1390

1.91

21.55

7.2

4.1

mmol/l

4.0

3.9

4.14

254

1302

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

289

1523

1.87

21.47

2.5

2.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

333

1853

1.77

20.72

1.6

titre

100.0

360.0

2.76

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

303

2.96

20.41

1.2

1.1

miu/ml

1479.4

1470.4

0.03

303

(3025159) Blasts/100 leukocytes in Blood

623

4075

1.52

20.36

5.2

4.5

0.0

0.2

1.03

188

951

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

241

1226

1.93

19.95

2.2

3.4

ratio

1.4

2.3

0.97

(3007461) Platelets [#/volume] in Blood

6938

65101

1.76

19.95

32.9

18.2

e9/l

244.1

255.2

39.34

6829

63344

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

236

1195

1.94

19.81

1.6

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

245

1260

1.91

19.64

2.3

3.4

mg/l

64.9

100.1

0.36

182

1022

(3020876) Protein [Mass/time] in 24 hour Urine

107

391

2.67

19.58

1.9

2.0

g/24h

0.7

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

245

1262

1.91

19.55

2.3

3.4

mg/l

52.2

60.7

0.30

181

1025

(3040893) Potassium [Moles/volume] in Capillary blood

9.70

19.48

3.8

3.2

mmol/l

4.4

4.6

0.58

(3017181) Myelocytes/100 leukocytes in Blood

670

4490

1.49

19.46

5.2

4.4

0.8

0.9

0.12

222

1219

(3040151) Glucose [Moles/volume] in Capillary blood

143

601

2.33

19.46

4.3

5.8

mmol/l

6.5

7.1

1.68

129

495

(3039000) Anion gap in Blood

212

1042

2.00

19.39

13.9

7.2

mmol/l

10.9

11.4

1.43

190

923

(46235355) HIV 1 and 2 tests - Meaningful Use set

1822

14392

1.30

19.34

2.6

2.0

—

(3018572) Chloride [Moles/volume] in Blood

212

1043

2.00

19.34

13.9

7.2

mmol/l

106.1

105.2

1.87

190

924

(3024731) MCV [Entitic volume]

6939

65153

1.74

19.33

32.7

18.1

90.0

0.01

6893

64304

(3035941) MCH [Entitic mass]

6939

65154

1.74

19.31

32.7

18.1

30.0

30.1

6.87

6894

64305

(3026361) Erythrocytes [#/volume] in Blood

6940

65166

1.75

19.31

32.8

18.2

e12/l

4.5

4.6

50.20

6817

63256

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1733

13610

1.30

19.19

1.8

1.6

mmol/l

1.4

0.13

1534

11677

(3000963) Hemoglobin [Mass/volume] in Blood

6941

65189

1.74

19.14

33.3

18.3

g/l

132.5

136.8

92.61

6896

64342

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5679

51485

1.31

19.07

4.9

4.5

mu/l

2.0

2.1

0.95

5340

47808

(3010813) Leukocytes [#/volume] in Blood

6941

65194

1.74

19.07

32.9

18.2

e9/l

6.8

6.7

0.87

6823

63275

(3018405) Lactate [Moles/volume] in Arterial blood

298

1649

1.78

18.91

6.8

3.9

mmol/l

1.2

1.4

6.13

293

1621

(3009542) Hematocrit [Volume Fraction] of Blood

6029

55146

1.35

18.88

24.7

13.4

39.0

40.3

28.58

4805

43090

(3021440) Promyelocytes/100 leukocytes in Blood

642

4291

1.49

18.88

5.2

4.5

0.1

0.19

210

1133

(3002179) Metamyelocytes/100 leukocytes in Blood

619

4122

1.50

18.53

4.7

4.2

0.7

0.6

1.17

163

882

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

273

1482

1.81

18.48

1.3

1.5

iu/ml

7.7

16.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

4.99

18.17

6.8

6.7

70.9

74.4

0.37

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6506

60326

1.43

18.08

14.1

9.6

u/l

27.1

27.4

0.13

6370

58375

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

121

489

2.42

18.01

1.3

1.2

u/l

121.5

82.5

0.45

343

(3051593) INR in Capillary blood by Coagulation assay

174

3.47

17.92

9.4

10.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

109

421

2.53

17.88

1.7

1.4

e6/l

67724.2

83495.0

0.18

242

(3023199) Leukocytes [#/volume] in Pleural fluid

119

479

2.43

17.87

1.8

1.5

e6/l

1847.2

2405.8

0.50

342

(3005719) IgG [Mass/volume] in Serum or Plasma

691

4736

1.46

17.86

3.1

2.8

g/l

10.0

10.3

1.09

662

4374

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

117

4.07

17.81

4.2

4.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1866

14922

1.28

17.73

4.8

3.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

159

731

2.13

17.45

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5330

48100

1.27

17.37

6.0

5.1

mmol/mol

38.2

39.0

7.83

5061

45029

(3004588) Protein electrophoresis panel - Serum or Plasma

455

2884

1.56

17.11

1.8

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

159

741

2.10

16.86

1.4

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2369

19590

1.25

16.81

2.0

1.9

pmol/l

95.6

96.4

0.41

1363

10438

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

110

4.07

16.70

1.8

2.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

310

1798

1.70

16.69

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

198

1009

1.92

16.37

1.6

1.5

—

(3003338) MCHC [Mass/volume]

5663

51629

1.28

16.12

28.2

15.7

g/l

332.6

333.6

13.13

5634

51220

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4857

43521

1.24

15.92

4.1

3.8

pmol/l

14.8

14.6

3.63

4525

39846

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

218

1164

1.84

15.62

4.0

3.8

56.6

56.4

0.10

218

1164

(3045788) Cell count panel - Pleural fluid

373

2.51

15.61

1.8

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

209

3.03

15.14

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

545

3686

1.47

15.04

1.8

1.9

g/l

1.2

1.3

0.38

526

3420

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

215

1160

1.82

14.91

1.7

2.2

g/l

0.0

0.50

194

1079

(40760888) Immunoglobulin light chains.free panel - Serum

185

952

1.90

14.89

2.3

3.5

—

(3012441) Differential panel - Pleural fluid

101

411

2.40

14.89

1.6

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.59

14.87

1.8

ng/l

120.7

135.3

0.23

(40760892) CBC W Ordered Manual Differential panel - Blood

1622

12988

1.27

14.81

6.0

4.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

247

1398

1.73

14.56

1.8

2.3

g/l

0.3

0.9

4.77

214

1236

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

212

1148

1.81

14.54

1.7

2.2

g/l

0.0

0.00

194

1078

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

226

1255

1.77

14.25

1.7

2.2

g/l

0.0

1.39

205

1169

(3021879) Hepatitis B virus core Ab [Presence] in Serum

724

5215

1.38

14.03

2.0

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

118

528

2.18

13.96

1.7

1.5

g/l

29.2

33.6

3.36

104

477

(3009871) Measles virus Ab [Titer] in Serum

204

2.96

13.90

1.7

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

220

2.88

13.86

1.2

1.1

83.8

90.4

0.93

101

(4035726)

613

4311

1.41

13.67

1.8

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.35

13.64

1.4

1.2

—

(40761536) Microorganisms panel - Urine sediment

662

4721

1.39

13.61

6.5

3.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

147

3.31

13.53

1.2

1.1

81.1

77.0

0.22

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

310

1906

1.60

13.32

1.6

1.7

g/l

1.2

0.52

301

1809

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

263

1553

1.66

13.29

1.8

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

220

2.83

13.29

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

397

2.33

13.24

1.6

—

(3003181) Sodium [Moles/volume] in Urine

165

852

1.89

13.19

1.7

1.8

mmol/l

68.2

67.1

0.10

138

691

(3035947) Staphylolysin Ab [Units/volume] in Serum

259

2.67

13.18

1.1

iu/ml

5.0

4.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

222

2.81

13.07

3.0

1.9

u/ml

336.2

21228.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

212

2.85

13.00

1.3

1.2

75.7

89.7

2.00

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

224

1277

1.72

12.91

1.6

2.1

g/l

37.7

37.9

0.20

198

1122

(3047185) IgG [Mass/volume] in Urine

27.47

12.73

1.0

—

(3025941) Bacteria identified in Stool by Culture

489

3345

1.44

12.71

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

802

5958

1.34

12.71

9.7

6.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

149

3.20

12.59

1.3

1.1

67.3

65.6

0.08

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

255

1516

1.65

12.57

1.8

2.3

g/l

10.1

10.3

0.22

217

1311

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.88

12.38

1.1

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1542

1.63

12.23

1.8

2.3

g/l

3.1

0.14

209

1231

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5569

51145

1.23

12.05

4.6

3.6

mmol/l

1.3

0.52

5292

47618

(44806071)

4.14

12.00

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

506

3521

1.42

11.98

3.7

3.3

pmol/l

4.6

0.27

461

3170

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

429

2.20

11.87

2.3

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

296

1853

1.57

11.81

1.6

1.7

g/l

0.2

0.52

288

1758

(3020393) Adenovirus Ag [Presence] in Stool

193

2.82

11.62

1.9

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

136

688

1.93

11.62

1.8

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

1005

7809

1.28

11.42

1.4

titre

492.5

530.9

0.25

185

1514

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

119

580

2.00

11.32

2.0

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

265

1634

1.59

11.30

1.8

2.3

g/l

3.7

3.8

0.74

204

1199

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

265

1635

1.59

11.27

1.8

2.3

g/l

7.1

7.4

1.13

212

1255

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

265

1635

1.59

11.27

1.8

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

281

2.46

11.22

1.4

1.2

u/l

28.5

23.1

0.42

241

(21494755) Public health laboratory ask at order entry panel

512

6671

0.72

11.04

1.3

—

(3019150) Specific gravity of Urine by Refractometry

1473

12009

1.23

11.03

5.7

3.6

kg/l

1.0

1.04

210

1820

(3000570) Elastase.pancreatic [Mass/mass] in Stool

247

1511

1.60

10.90

1.4

ug/g

289.9

293.3

0.09

142

844

(3011985) Renin [Units/volume] in Plasma

139

729

1.86

10.68

1.4

1.6

mu/l

91.2

72.2

0.24

123

656

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1066

8412

1.27

10.63

2.7

2.9

mmol/l

2.4

0.66

905

7370

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

263

1655

1.56

10.30

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

293

2.36

10.28

1.4

1.2

u/l

114.7

90.5

0.50

255

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

119

603

1.92

10.17

1.7

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

264

1672

1.55

10.06

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

265

1683

1.54

9.98

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

577

4230

1.35

9.95

1.3

u/ml

209.8

258.3

0.91

552

3927

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

380

2.15

9.80

1.9

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5762

53415

1.21

9.68

5.0

4.0

mmol/l

4.4

4.7

64.79

5520

50157

(3036481) Cortisol [Moles/volume] in Serum or Plasma

727

5532

1.30

9.65

2.6

2.3

nmol/l

357.6

367.2

0.60

683

5115

(3007164) IgA [Mass/volume] in Serum or Plasma

1589

13217

1.21

9.58

1.6

1.5

g/l

2.1

2.2

1.90

1014

7977

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5719

52992

1.21

9.58

5.0

3.9

mmol/l

1.4

7.82

5462

49540

(3011412) CD3 cells [#/volume] in Blood

135

730

1.80

9.45

2.3

2.8

e9/l

1.2

1.3

0.49

449

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4804

43856

1.18

9.44

3.5

3.3

—

(3018133) Calcium [Moles/volume] in Urine

245

2.42

9.41

2.4

3.3

mmol/l

2.5

2.6

0.09

227

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

310

2066

1.47

9.29

2.0

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

195

1175

1.62

9.22

4.2

2.4

ug/min

128.0

113.7

0.20

142

747

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

117

610

1.87

9.22

2.0

2.7

13.8

11.4

1.23

372

(3045414) Leukocytes [Presence] in Urine

346

2360

1.44

9.19

2.3

1.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

148

2.82

9.02

1.8

2.0

e6/l

7568.2

15780.1

0.27

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.49

8.86

1.5

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

127

689

1.80

8.83

1.3

1.4

pmol/l

403.5

330.8

0.75

104

532

(3023419) Bacteria identified in Sputum by Culture

111

578

1.87

8.80

2.2

3.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

159

924

1.68

8.68

1.7

—

(3033799) Differential panel - Peritoneal fluid

141

2.82

8.63

2.3

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5807

54025

1.20

8.59

5.4

4.3

mmol/l

2.6

2.8

49.89

5536

50400

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

281

1869

1.47

8.54

1.9

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

103

532

1.89

8.39

1.2

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

177

2.58

8.33

5.5

4.3

47.5

51.3

0.55

171

(3023487) Leukocytes [#/volume] in Peritoneal fluid

166

2.63

8.31

2.2

e6/l

16805.8

767.0

0.48

123

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

206

2.45

8.31

2.9

2.7

ug/l

115.3

96.0

0.33

201

(40768804) Tissue Pathology biopsy report

2401

20905

1.17

8.29

2.1

2.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

280

2.22

8.18

1.6

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

238

2.33

8.12

4.5

3.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

156

919

1.66

8.12

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

260

2.24

7.86

2.1

1.6

u/field

3.0

3.5

0.18

196

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

105

559

1.83

7.81

2.4

3.0

e9/l

0.2

0.94

450

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

286

2.18

7.79

1.6

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

391

1.99

7.70

2.0

2.9

21.3

28.0

4.98

377

(3013005) Retinol [Moles/volume] in Serum or Plasma

413

1.96

7.60

3.5

2.8

umol/l

1.8

0.13

397

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

106

572

1.80

7.56

2.4

2.9

e6/l

474.9

544.0

0.67

452

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

449

1.91

7.49

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

449

1.91

7.49

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

449

1.91

7.49

1.4

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4227

38532

1.15

7.39

4.0

3.1

u/l

47.0

44.4

1.44

4037

36348

(40768797) Stomach Pathology biopsy report

867

6961

1.23

7.30

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

317

2223

1.40

7.27

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

309

2.08

7.16

1.4

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

110

611

1.75

7.15

3.9

4.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

258

1753

1.44

7.08

1.6

1.9

—

(3045424) Erythrocytes [Presence] in Urine

148

895

1.61

7.00

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

230

2.24

6.96

1.2

1.1

u/l

81.4

91.2

0.29

184

(3016244) Insulin [Units/volume] in Serum or Plasma

113

638

1.72

6.95

4.0

3.2

mu/l

20.3

25.0

1.04

107

603

(3035880) pH of Pleural fluid

212

2.29

6.94

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

237

1592

1.46

6.92

3.0

3.6

u/ml

362.6

3369.3

1.02

210

1361

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

469

1.85

6.89

5.5

2.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

213

2.28

6.87

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

213

2.28

6.87

1.7

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

295

2.08

6.85

1.8

1.6

u/l

7.6

5.3

0.55

152

(3004809) Band form neutrophils/100 leukocytes in Blood

137

818

1.63

6.83

4.0

3.5

1.2

1.3

0.23

123

626

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

271

2.12

6.75

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

228

2.22

6.68

1.2

1.1

u/l

22.5

25.8

0.19

174

(3042631) Mycobacterium sp identified in Specimen

107

602

1.73

6.68

2.2

2.9

—

(3022229) Phosphate [Moles/volume] in Urine

156

2.49

6.67

2.6

2.9

mmol/l

18.7

20.3

0.26

147

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.98

6.58

1.5

1.8

mg/l

1.0

2.1

1.10

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.98

6.58

1.5

1.8

mg/l

1.0

1.6

0.60

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.98

6.58

1.5

1.8

mg/l

2.2

4.0

1.15

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.98

6.58

1.5

1.8

mg/l

0.5

1.1

1.23

(3014891) Appearance of Pleural fluid

3.57

6.54

2.1

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

193

1261

1.49

6.50

1.6

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

141

2.55

6.48

1.5

1.1

—

(3021788) Differential panel - Synovial fluid

145

891

1.59

6.45

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

177

1143

1.51

6.32

1.9

1.6

e6/l

19663.5

12612.2

0.43

124

827

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

335

2428

1.35

6.31

2.3

2.4

—

(3000060) B lymphocytes [#/volume] in Blood

360

1.92

6.23

2.0

3.0

e6/l

377.8

300.3

0.58

217

(40768806) Pleura Pathology biopsy report

422

1.84

6.22

1.7

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

514

1.76

6.20

3.2

2.2

mmol/l

4.1

4.0

0.39

506

(3016038) Potassium [Moles/volume] in Urine

381

1.89

6.20

1.6

1.9

mmol/l

33.4

35.8

0.35

344

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.23

6.17

1.3

1.4

ml/s/173m2

0.6

1.7

6.84

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

146

2.46

6.05

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

497

1.76

6.03

3.2

2.3

—

(3037756) Immunofixation for Serum or Plasma

135

831

1.58

6.00

1.3

1.7

—

(3035285) Chloride [Moles/volume] in Venous blood

513

1.74

5.97

3.2

2.3

mmol/l

106.2

105.4

1.33

505

(21494815) CD4 cells/100 lymphocytes in Specimen

114

675

1.64

5.93

2.1

2.8

41.1

42.8

0.12

(3044007) Cell count panel - Peritoneal fluid

136

2.50

5.92

1.8

2.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.40

5.82

1.1

1.6

17.9

7.4

0.70

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

363

1.87

5.77

2.5

2.1

u/field

1.5

1.8

0.29

165

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

276

2.01

5.73

1.5

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

103

600

1.67

5.72

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

164

1069

1.50

5.65

3.8

2.9

umol/l

14.6

7.4

2.09

136

809

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

122

746

1.59

5.60

1.5

1.3

nmol/l

0.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

275

1.98

5.44

1.5

1.6

—

(3022145) Colonoscopy Study observation

706

5732

1.21

5.32

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.75

5.16

1.1

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

315

1.88

5.14

2.4

2.9

umol/l

35.9

102.9

3.17

(21494890) Protein electrophoresis panel - 24 hour Urine

428

1.75

5.11

1.7

2.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

110

674

1.59

5.05

1.5

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

3.17

5.00

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1188

10141

1.16

4.98

1.6

pmol/l

54089115.1

28781766.5

0.58

1015

8575

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

368

1.80

4.95

4.1

2.9

umol/l

25.7

26.8

0.49

358

(42870560) Thyrotropin [Units/volume] in Cord blood

370

1.79

4.87

1.0

mu/l

9.4

8.6

0.36

323

(3048689) Calprotectin [Mass/mass] in Stool

967

8142

1.17

4.83

2.4

2.7

ug/g

145.6

125.5

0.63

753

6497

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

127

814

1.52

4.80

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

202

1415

1.39

4.80

1.6

2.0

mg/l

11.8

10.9

0.66

187

1328

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

305

2277

1.31

4.77

1.6

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

275

1.91

4.77

1.6

1.3

u/l

9.9

12.6

0.98

254

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

498

5843

0.81

4.76

1.7

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

152

2.23

4.70

1.2

1.5

60.9

60.6

0.02

127

(3000330) Specific gravity of Urine by Test strip

315

2367

1.30

4.70

5.0

3.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

11.07

4.68

1.1

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

362

1.77

4.62

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

302

2263

1.30

4.61

1.7

1.9

u/l

37.4

39.3

0.94

261

2033

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5509

51697

1.13

4.60

4.7

4.0

mmol/l

5.8

1.72

5134

47695

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.38

4.36

1.7

1.4

umol/24h

252.3

321.3

1.05

(3015171) Extractable nuclear Ab [Units/volume] in Serum

284

2130

1.30

4.33

1.3

1.2

u/ml

0.9

1.0

0.10

181

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

494

3957

1.22

4.30

2.3

au/ml

22.5

21.9

0.05

241

(40761539) Cells [Type] in Urine sediment by Light microscopy

140

2.22

4.26

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.53

4.25

1.2

1.5

ng/l

80.5

55.4

0.26

(40768441) Liver Pathology biopsy report

438

1.66

4.23

1.7

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1675

14782

1.13

4.21

1.4

u/ml

1.4

2.2

2.35

424

3728

(3019225) pH of Specimen

572

4660

1.20

4.20

10.1

4.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

8.61

4.18

3.8

4.2

mmol/l

140.3

138.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

120

785

1.49

4.17

1.1

1.3

u/l

32.0

38.3

0.29

106

684

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

536

1.58

3.99

1.2

1.3

titre

89.0

197.2

—

118

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

184

2.00

3.93

2.4

2.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.51

3.86

1.2

1.1

pmol/l

3.3

6.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

153

2.09

3.84

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

160

1123

1.39

3.84

1.2

u/ml

3.5

4.5

0.16

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

7.04

3.76

1.8

1.4

umol/l

458.8

144.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

545

1.55

3.74

2.6

2.7

e6/l

631.2

726.8

0.53

172

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

334

3964

0.81

3.62

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

236

1773

1.30

3.61

1.3

1.4

—

(3019174) dRVVT (LA screen)

2.75

3.55

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

449

3636

1.21

3.55

1.2

1.3

au/ml

42.7

49.5

0.19

143

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

243

1.80

3.41

1.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

1961

20357

0.91

3.37

2.9

2.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

187

1376

1.32

3.36

2.1

1.9

iu/l

3.1

4.7

3.46

514

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.72

3.34

1.3

1.5

—

(3019977) pH of Arterial blood

252

1.77

3.34

3.1

2.7

7.4

1.72

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

217

1.83

3.32

2.4

2.5

—

(3000012) Reticulocyte production index

253

1.76

3.30

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

259

2000

1.26

3.23

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

131

2.07

3.23

1.3

1.2

g/l

42.0

38.9

0.37

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

351

1.63

3.19

2.6

34.0

41.0

1.74

106

(4010399)

449

3678

1.19

3.17

1.5

1.4

—

(3045716) Anion gap in Serum or Plasma

214

1.81

3.15

4.2

2.4

mmol/l

8.8

9.6

0.69

164

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

139

2.02

3.14

1.2

1.1

—

(4062490)

103

697

1.44

3.11

1.3

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

146

1049

1.35

3.10

1.4

1.7

g/l

0.7

0.8

0.73

113

815

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

525

4376

1.17

3.03

3.1

4.1

ug/l

5.5

23.0

4.30

407

3486

(3037692) Legionella sp identified in Specimen by Organism specific culture

175

1.88

3.03

1.8

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

251

1951

1.25

2.99

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

186

1394

1.30

2.97

1.2

1.3

u/ml

2.2

6.4

1.10

139

(3044941) Cell count panel - Synovial fluid

111

769

1.40

2.96

1.8

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

274

3244

0.81

2.96

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

188

1413

1.29

2.94

1.2

1.3

u/ml

5.2

10.1

1.23

213

(1761482) Bacteria [#/volume] in Urine by Culture

150

1093

1.33

2.93

5.5

3.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

101

691

1.42

2.90

1.3

1.4

g/l

0.4

0.17

502

(3027135) IgG subclass 1 [Mass/volume] in Serum

101

692

1.42

2.88

1.3

1.4

g/l

7.2

6.7

0.65

505

(3028192) IgG subclass 2 [Mass/volume] in Serum

101

692

1.42

2.88

1.3

1.4

g/l

2.8

0.08

507

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.25

2.85

2.0

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

201

1.78

2.81

1.4

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1615

14509

1.10

2.80

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.66

2.80

1.4

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

5.21

2.79

1.1

1.5

mmol/24h

1.7

2.1

—

(3020650) Glucose [Presence] in Urine

160

1.88

2.76

1.3

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.04

2.76

1.0

1.1

g/l

17.0

16.7

0.05

(40757373) Influenza virus identified in Isolate

100

2.13

2.76

1.4

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

413

1.53

2.72

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

247

1.69

2.71

1.0

1.2

—

(3003129) Base excess in Capillary blood by calculation

114

2.04

2.70

1.1

1.8

mmol/l

-2.1

0.7

3.06

107

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

155

1150

1.31

2.70

1.5

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

360

1.56

2.69

1.1

1.2

u/ml

7.1

16.0

—

(3017704) Immunofixation for Urine

226

1.72

2.67

1.3

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

160

1196

1.30

2.64

3.0

2.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

409

1.52

2.62

1.1

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

378

1.54

2.62

1.1

1.2

u/ml

70.2

44.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

143

1056

1.32

2.59

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

198

1528

1.26

2.56

1.2

1.3

u/ml

1.6

35.4

5.16

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

412

1.51

2.55

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

580

1.42

2.52

1.1

—

(3036603) Volume of Urine

336

1.56

2.51

1.5

1.6

1595.6

2031.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.49

2.48

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

181

1.77

2.46

1.9

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

427

3571

1.17

2.42

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

204

1.71

2.41

1.7

2.2

—

(3044290) Cell count panel - Cerebral spinal fluid

176

1352

1.27

2.39

1.4

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

380

1.51

2.36

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

198

1.71

2.36

1.7

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

198

1.71

2.36

1.7

2.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

289

1.58

2.32

1.5

1.4

u/ml

21.3

20.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

290

1.57

2.29

2.0

2.9

umol/l

246.8

170.3

0.39

163

(3049233) Organic acids panel - Urine

2.31

2.29

1.4

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.99

2.28

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

407

3409

1.16

2.28

2.1

2.3

u/l

7869.7

6380.3

0.31

153

1268

(3020961) Endomysium IgA Ab [Titer] in Serum

415

3485

1.16

2.25

1.2

titre

379.0

219.0

—

117

(4281824)

442

1.45

2.21

1.4

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

2.53

2.20

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

141

1067

1.28

2.19

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

427

1.45

2.18

1.8

1.4

e6/l

135284.2

70510.1

0.33

300

(21494814) CD8 cells/100 lymphocytes in Specimen

233

1.62

2.18

1.9

2.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

325

1.52

2.17

1.2

—

(3022621) pH of Urine by Test strip

401

3370

1.16

2.17

3.6

2.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

132

1.84

2.14

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

208

1652

1.22

2.13

1.4

titre

93.0

97.9

0.08

155

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

161

1243

1.26

2.13

1.1

au/ml

13.7

14.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

600

1.37

2.13

1.6

—

(3044927) Protein electrophoresis panel - Urine

406

1.46

2.12

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

183

1.69

2.11

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

626

1.36

2.11

1.4

1.7

mosm/kgh2o

286.6

283.7

0.64

479

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

258

1.58

2.11

1.6

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

258

1.58

2.11

1.6

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

258

1.58

2.11

1.6

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

258

1.58

2.11

1.6

2.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

333

0.52

2.08

1.4

mmol/l

5.4

5.6

0.40

315

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.96

2.07

1.4

1.2

ug/l

86.6

429.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

345

1.49

2.06

3.0

2.5

umol/l

64.3

54.8

1.05

302

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

711

6226

1.12

2.05

1.7

1.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.54

2.04

1.0

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

713

1.33

2.04

1.2

1.3

u/ml

79.1

47.5

—

(3017569) Oxygen content in Arterial blood

215

1.62

2.03

1.9

2.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

114

1.87

2.01

1.6

1.5

nmol/l

19.4

16.0

0.50

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

534

1.38

1.98

1.2

1.4

mmol/l

10.4

11.4

0.42

135

(3028433) Virus identified in Specimen by Culture

225

1.59

1.95

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

233

1.58

1.94

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.19

1.92

1.6

1.3

mmol/l

1.4

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

687

1.33

1.92

1.4

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

157

1227

1.24

1.90

1.2

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

497

1.39

1.90

1.1

1.2

—

36.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.01

1.90

1.3

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

336

1.47

1.90

1.6

1.7

u/l

5.5

6.8

0.83

293

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

473

1.39

1.89

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

212

1.60

1.89

1.0

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

4.40

1.88

1.2

1.3

nmol/l

164.0

238.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

157

1229

1.24

1.88

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

131

1.78

1.88

1.9

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

491

4234

1.13

1.86

1.2

iu/ml

120.3

152.3

1.15

178

1516

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.86

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

632

1.34

1.86

1.8

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.64

1.85

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

608

1.34

1.84

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

567

1.35

1.83

1.7

2.1

mg/l

23.9

22.3

0.08

152

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

634

1.33

1.83

1.8

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

477

1.38

1.82

1.1

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

1.73

1.81

3.8

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

1.73

1.81

3.8

2.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

636

1.33

1.79

1.8

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.96

1.79

1.4

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

373

1.43

1.78

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1702

15600

1.07

1.77

4.3

4.4

ug/l

1.9

2.5

4.42

1513

14155

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

278

1.50

1.77

1.2

—

(3004451) EKG impression Narrative

216

1.57

1.77

1.5

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

180

1444

1.21

1.73

1.3

1.8

mmol/l

3.7

3.6

0.44

168

1359

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

157

1.67

1.72

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

157

1.67

1.72

1.4

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

474

1.37

1.72

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

616

1.32

1.71

1.2

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.23

1.68

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

180

1449

1.21

1.68

1.4

2.0

e6/l

4.7

23.2

3.35

136

1103

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

180

1450

1.21

1.67

1.4

2.0

e6/l

388.5

3626.7

0.68

142

1161

(3017354) Segmented neutrophils/100 leukocytes in Blood

479

1.36

1.63

2.9

3.5

63.1

56.2

1.73

292

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

447

1.37

1.61

3.5

4.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

109

1.78

1.60

1.1

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.06

1.60

1.7

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

640

1.30

1.60

1.8

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

640

1.30

1.60

1.8

1.4

—

(3011048) Pyruvate [Moles/volume] in Blood

102

1.80

1.60

1.8

1.3

umol/l

81.4

95.7

1.41

(3032057) Clostridioides difficile [Presence] in Stool

1.84

1.59

3.7

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

473

1.35

1.58

1.1

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.71

1.58

6.4

5.2

—

(3000034) Microalbumin [Mass/volume] in Urine

457

1.36

1.57

2.8

3.0

mg/l

121.2

60.4

0.83

337

(3013931) Oligosaccharides [Presence] in Urine

3.46

1.56

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.89

1.55

2.6

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

235

1955

1.17

1.54

1.8

1.6

iu/ml

3.4

0.00

420

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

687

1.29

1.53

1.1

—

21.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

705

1.28

1.52

1.1

—

14.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

148

1.64

1.52

2.3

1.3

60.3

53.1

0.40

130

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

654

1.29

1.52

1.8

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

477

1.34

1.51

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

477

1.34

1.51

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

926

8346

1.08

1.51

2.0

1.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

157

1.60

1.47

1.5

1.2

—

(3034614) HLA Ag [Interpretation]

3.23

1.47

1.0

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

2.77

1.45

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.77

1.45

1.0

—

(4034850)

201

1662

1.17

1.44

12.5

8.6

—

(40768793) Breast Pathology biopsy report

990

0.78

1.43

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.76

1.42

1.5

ug/l

0.6

0.4

0.46

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

196

1620

1.18

1.41

1.4

1.8

mg/l

443.1

488.5

1.11

185

1543

(3044242) Glucose [Moles/volume] in Arterial blood

229

1.48

1.41

1.9

2.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.64

1.38

3.5

4.6

—

(3000492) Spirometry study

636

5669

1.09

1.37

1.5

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

320

1.39

1.36

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

426

0.68

1.31

1.8

2.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.42

1.31

1.0

1.1

—

(3032641) Amino acids panel - Urine

2.10

1.29

1.1

1.2

—

(4133840)

168

0.52

1.29

1.3

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.35

1.28

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

432

1.32

1.28

3.6

2.2

—

(3007463) Buprenorphine [Presence] in Urine

2.07

1.28

4.8

5.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

211

0.55

1.27

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

300

1.39

1.27

1.0

kpa

3.1

3.3

0.40

257

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

923

8383

1.07

1.26

1.5

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.42

1.25

1.0

23.8

21.2

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.42

1.25

1.0

38.9

36.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

244

1.43

1.25

2.5

2.7

mg/l

8.9

9.6

0.32

209

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

326

1.37

1.24

1.5

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

326

1.37

1.24

1.5

2.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.74

1.24

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

2.69

1.24

1.8

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.97

1.22

1.2

1.1

—

(4015189)

112

1.64

1.21

3.7

2.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

262

1.41

1.21

1.4

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

274

2354

1.13

1.20

1.4

1.3

miu/ml

180.0

221.2

1.12

105

1104

(3005011) Chlamydia sp Ab [Titer] in Serum

120

1.61

1.20

1.3

1.4

—

(3006598) pH of Arterial cord blood

304

1.37

1.19

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

304

1.37

1.19

1.0

mmol/l

-1.9

-2.3

0.17

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

304

1.37

1.19

1.0

kpa

7.0

7.3

0.46

260

(36660697) Celiac disease serology panel - Serum

625

5607

1.09

1.19

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

653

1.25

1.18

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

165

0.53

1.18

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.78

1.18

1.4

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1041

10643

0.94

1.17

2.1

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

139

1138

1.19

1.17

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

594

1.26

1.16

1.5

1.6

63.5

56.1

1.05

376

(3009214) Lutropin [Units/volume] in Serum or Plasma

291

2521

1.12

1.13

2.0

1.6

u/l

9.0

8.1

0.52

224

1951

(3023420) DNA double strand Ab [Units/volume] in Serum

624

1.24

1.11

1.8

1.5

iu/ml

38.8

25.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

812

8353

0.93

1.11

1.8

1.5

1.4

1.84

734

7466

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.99

1.10

2.3

1.8

—

(4146454)

488

0.73

1.10

2.8

2.7

—

(3027944) Amphetamines [Presence] in Urine

372

3952

0.91

1.10

1.8

2.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

602

1.24

1.05

1.7

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.72

1.05

1.5

1.2

mmol/l

1.5

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

352

3096

1.11

1.05

1.9

1.5

iu/l

24.2

22.0

0.56

292

2518

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.12

1.05

1.6

1.2

u/l

8660.1

286.3

—

(4094501)

160

1341

1.16

1.04

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

378

4000

0.91

1.04

1.8

2.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

313

1.33

1.02

1.7

1.6

iu/ml

—

1656666.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

677

0.78

1.02

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

458

1.27

1.01

1.9

1.5

23.8

33.0

1.60

288

(3017732) Neutrophils [#/volume] in Blood

438

3902

1.09

1.01

2.4

2.6

e9/l

4.1

0.09

353

3172

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

450

1.27

1.01

1.3

u/ml

2.2

1.0

0.42

163

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

190

1.43

1.00

1.7

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1058

0.83

1.00

1.0

1.1

u/ml

0.9

0.5

0.17

318

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

182

1.44

1.00

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

174

1.45

1.00

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

128

0.53

0.98

1.3

—

(3014271) Vancomycin [Susceptibility]

191

1.42

0.98

2.6

2.7

—

(40760409) HLA-A [Type] by High resolution

0.00

0.97

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.97

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.97

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

104

1.58

0.97

2.4

2.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.81

0.97

1.1

1.2

umol/24h

1.5

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

958

9753

0.94

0.96

2.0

2.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

136

1.50

0.95

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

272

2377

1.11

0.95

2.5

3.1

u/ml

38.4

50.2

0.71

267

2293

(43055514) Macroprolactin [Presence] in Serum or Plasma

209

1.39

0.94

1.2

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

250

0.66

0.94

1.0

—

9.6

—

(3027008) Opiates [Presence] in Urine

383

4027

0.92

0.94

1.8

2.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

234

1.37

0.94

1.1

1.2

g/l

0.3

0.25

190

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

217

2348

0.89

0.93

1.6

1.7

mg/l

4.5

3.9

0.27

145

1598

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.23

0.93

1.0

—

(3028300) Cannabinoids [Presence] in Urine

384

4035

0.92

0.93

1.9

2.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

251

1.35

0.93

1.1

1.3

—

60.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

137

0.56

0.93

1.3

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

334

2955

1.10

0.92

1.2

1.1

u/ml

2.7

12.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

612

0.79

0.91

1.4

1.6

mmol/l

7.6

7.5

0.06

373

(3008898) HLA-B27 [Presence]

216

2333

0.89

0.91

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

457

1.25

0.91

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

518

1.23

0.91

1.4

1.5

—

(3002619) Bacteria identified in Specimen by Culture

122

1.51

0.90

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

140

1178

1.15

0.90

1.2

u/ml

29.6

41.7

0.71

106

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

393

0.74

0.90

1.3

1.4

—

(40765096) Chromosome analysis panel by Banding

164

0.59

0.88

1.5

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.00

0.87

2.0

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.84

0.86

1.8

1.7

umol/l

35.3

44.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

426

1.25

0.86

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

116

1299

0.86

1.1

u/ml

9.3

5.5

0.83

608

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.76

0.83

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

472

1.23

0.83

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.87

0.81

1.0

—

(3023410) Appearance of Cerebral spinal fluid

757

1.18

0.81

1.6

2.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

110

1.50

0.79

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.73

0.79

1.5

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

431

1.24

0.79

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

111

929

1.16

0.79

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

259

1.31

0.79

1.1

ng/l

228.9

270.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.81

0.78

2.2

2.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

192

1.36

0.78

1.3

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

328

1.27

0.78

1.0

mmol/l

19.6

19.7

0.06

308

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.56

0.78

1.4

1.9

pmol/l

34.1

36.9

0.07

(3010726) Horse dander IgE Ab [Units/volume] in Serum

155

1686

0.89

0.77

1.1

u/ml

3.2

3.0

0.06

500

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

193

1.35

0.76

1.3

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.76

0.76

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

1088

1.14

0.75

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

287

1.28

0.75

1.7

1.6

nmol/l

2.0

5.0

1.01

231

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

641

5875

1.06

0.74

4.8

4.1

32.7

31.8

1.35

503

4106

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.72

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

390

4038

0.93

0.71

1.5

—

(40768443) Skin Pathology biopsy report

245

2172

1.09

0.70

1.2

—

(3016879) Cocaine [Presence] in Urine

359

3723

0.93

0.69

1.9

2.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

198

1.32

0.67

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

115

1.43

0.66

3.2

2.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.79

0.66

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

303

3155

0.93

0.65

1.9

2.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1325

12414

1.04

0.64

3.9

3.8

24.1

21.6

5.15

604

5504

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.58

0.64

1.0

—

3.4

—

(40758292) HTLV I+II Ab panel - Serum

124

0.62

0.64

1.1

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.53

0.63

1.5

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

243

1.28

0.63

1.3

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

133

1.38

0.63

1.1

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

109

931

1.13

0.63

1.4

u/l

19.4

21.0

0.25

786

(3047007) Chlamydophila sp Ab [Presence] in Serum

124

1069

1.12

0.62

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.61

0.61

4.6

2.4

u/field

0.1

0.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

244

2552

0.92

0.60

1.6

1.9

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.60

0.0

1.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.59

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.55

0.59

1.3

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

111

1206

0.89

0.59

1.0

1.1

u/ml

7.9

7.4

0.10

580

(3011897) Casein IgE Ab [Units/volume] in Serum

279

0.76

0.59

1.4

1.5

u/ml

2.7

8.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

103

1123

0.89

0.58

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

300

0.77

0.58

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.71

0.57

1.0

2.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.49

0.57

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

739

1.14

0.56

1.6

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

170

1.31

0.56

2.0

2.2

umol/l

18.0

16.1

0.37

170

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

186

1959

0.92

0.56

1.1

1.2

u/ml

4.1

2.0

0.72

1000

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

179

1.30

0.55

3.9

3.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.61

0.55

1.0

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.50

0.54

2.4

2.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

337

1.21

0.54

1.1

nmol/l

5.7

7.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.57

0.54

1.0

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

779

1.13

0.53

1.2

1.3

—

(3022670) pH of Venous cord blood

1.45

0.52

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

168

1770

0.92

0.52

1.0

1.1

u/ml

6.3

6.4

0.03

109

1087

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.51

0.52

1.3

1.1

—

(3011288) Drugs identified in Urine by Screen method

261

2700

0.93

0.51

2.2

3.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

528

1.16

0.51

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.40

0.51

1.5

2.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

556

0.85

0.50

4.8

4.5

u/ml

34.8

93.3

1.66

162

(4038314)

1.38

0.50

1.4

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.38

0.50

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

114

1.36

0.50

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

163

1715

0.92

0.50

1.0

1.1

u/ml

1.7

1.3

0.30

936

(4027681)

457

1.17

0.49

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

566

1.15

0.49

1.1

1.2

mg/l

31.1

41.5

2.78

466

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

233

2103

1.07

0.49

1.7

1.6

—

(44806420)

107

0.63

0.48

2.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.40

0.48

2.4

2.1

mmol/l

14.2

7.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

289

1.21

0.47

1.1

1.3

u/l

182.2

334.4

2.08

266

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.47

0.47

1.1

1.2

—

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

124

1.33

0.47

1.4

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

415

1.17

0.46

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

890

0.89

0.46

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

977

9170

1.04

0.46

1.3

iu/ml

25.5

29.9

0.56

268

2744

(3051387) C reactive protein [Mass/volume] in Capillary blood

130

1148

1.10

0.46

4.3

3.2

mg/l

25.4

25.6

0.02

685

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

178

1858

0.92

0.46

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

133

1.31

0.46

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.61

0.45

3.0

8.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

114

0.68

0.45

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

159

1.28

0.45

1.3

1.5

ug/l

11.0

8.5

1.15

159

(3027923) C peptide [Moles/volume] in Serum or Plasma

278

0.80

0.45

2.3

1.7

nmol/l

1.3

0.06

216

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

341

0.82

0.45

4.8

4.6

mg/l

7.8

8.4

0.28

275

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

172

1795

0.93

0.45

1.7

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

213

2204

0.93

0.44

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

545

1.14

0.43

1.4

promille

1.0

1.4

1.56

411

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

961

9031

1.03

0.43

2.9

2.8

ug/l

0.8

0.7

1.16

619

5609

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

527

1.14

0.43

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.37

0.43

1.1

umol/24h

0.6

0.7

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

374

1.17

0.42

1.8

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

592

1.13

0.42

1.5

1.3

—

33.9

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

296

0.82

0.42

1.2

1.3

u/ml

4.9

16.0

1.65

227

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.64

0.42

1.3

1.1

ug/l

75.9

77.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

411

0.85

0.42

1.3

1.5

—

(3024263) Appearance of Synovial fluid

258

1.20

0.42

2.1

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1003

0.91

0.41

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

154

1606

0.93

0.41

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

611

6125

0.96

0.41

2.0

2.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

549

1.13

0.40

1.1

iu/ml

7.1

8.6

0.17

124

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.47

0.40

1.0

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

1.37

0.40

2.2

2.9

ml/dl

16.4

15.0

0.92

(3025130) Human papilloma virus identified in Specimen

743

1.11

0.39

1.6

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

827

0.90

0.39

1.2

1.4

mmol/l

7.1

7.0

0.03

599

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

137

1.27

0.39

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

551

1.12

0.38

1.0

1.1

mg/l

241.5

259.0

0.36

482

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

351

1.16

0.38

1.0

1.1

u/l

1.0

1.1

1.71

164

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

561

0.88

0.38

1.4

1.3

pmol/l

95.2

121.1

0.18

164

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.36

0.37

8.8

3.7

umol/l

32.5

44.6

1.71

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

200

1.21

0.36

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

481

1.13

0.36

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.38

0.36

1.4

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.64

0.35

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

183

1.22

0.35

2.3

2.8

umol/l

28.1

29.1

0.13

132

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

113

1.28

0.35

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

309

2855

1.05

0.35

1.6

mu/l

359.6

307.0

0.98

280

2592

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.35

0.34

2.7

2.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

129

0.75

0.33

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

256

1.17

0.33

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.32

0.33

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

941

8894

1.03

0.32

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

106

1.28

0.32

1.1

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

159

1.22

0.32

1.1

u/ml

48.4

56.0

0.19

154

(3029396) Erythrocyte agglutination [Presence] in Blood

204

1.19

0.31

2.2

3.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.34

0.31

2.3

1.9

—

(40768795) Lymph node Pathology biopsy report

496

1.11

0.31

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

187

1910

0.95

0.30

1.4

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.30

0.30

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

277

1.15

0.30

1.4

1.3

nmol/l

138.1

135.7

0.10

277

(3050129) First trimester maternal screen panel - Serum or Plasma

260

2631

0.95

0.30

1.5

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

261

0.85

0.28

3.8

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

261

0.85

0.28

7.7

5.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

380

1.12

0.28

1.1

1.2

u/ml

5.2

19.9

0.99

271

(21494434) Karyotype in Bone marrow

463

1.11

0.28

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

105

1088

0.93

0.28

1.1

iu/ml

60.1

9157.3

0.62

287

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

199

2021

0.95

0.27

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate

322

0.87

0.27

1.1

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

200

2030

0.95

0.27

1.5

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

124

0.78

0.27

1.1

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

200

2028

0.95

0.26

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

502

4996

0.97

0.26

1.9

2.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.28

0.26

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

200

2026

0.95

0.26

1.5

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

123

0.79

0.25

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

123

1262

0.94

0.25

3.0

2.3

nmol/l

1.1

0.8

2.48

106

1068

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

175

0.83

0.25

2.0

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.29

0.25

1.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

195

0.84

0.24

1.1

1.9

nmol/l

5.3

4.6

0.27

186

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.70

0.23

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.27

0.23

1.0

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.27

0.22

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

239

1.13

0.22

1.1

—

(3020491) Glucose [Moles/volume] in Blood

424

1.10

0.22

1.8

mmol/l

5.8

6.4

1.54

308

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

124.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.18

0.21

1.0

1.2

u/l

1.8

18.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

145

1470

0.95

0.21

1.5

1.8

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.26

0.21

1.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.26

0.21

1.6

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

100

0.77

0.21

1.4

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

149

1.17

0.21

1.2

1.5

—

(3017509) Phencyclidine [Presence] in Urine

1.24

0.21

1.5

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.20

0.0

1.2

—

(3047189) Immunofixation for 24 hour Urine

205

1.13

0.19

1.5

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

559

1.07

0.19

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

105

1.20

0.19

1.0

1.1

u/ml

0.8

3.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

105

966

1.05

0.18

1.1

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

107

986

1.05

0.18

4.2

5.3

umol/l

367.6

379.4

0.40

874

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

253

1.11

0.17

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

106

1.19

0.17

1.0

1.1

u/ml

0.1

0.2

—

(3030313) Adrenal Ab [Titer] in Serum

1.21

0.17

1.1

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.13

0.17

3.0

2.7

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.73

0.17

2.0

2.5

pmol/l

49.3

75.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

125

1.16

0.16

1.7

2.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

101

1024

0.95

0.16

1.1

u/ml

2.0

3.7

1.16

465

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

157

1465

1.04

0.16

1.8

2.0

pmol/l

186.4

201.6

1.13

151

1392

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.76

0.15

10.7

9.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

246

1.10

0.15

1.4

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

105

1061

0.96

0.15

1.7

1.5

nmol/l

0.4

0.03

851

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.15

0.15

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

106

1070

0.96

0.15

1.4

ug/l

6.6

4.7

0.53

987

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

595

0.94

0.14

1.1

—

(3042517) Benzodiazepines panel - Urine

1.17

0.14

2.4

2.5

—

(1002224) Polysomnography panel

258

2434

1.03

0.14

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

369

1.08

0.14

1.6

—

(4024509)

454

1.07

0.14

1.4

1.5

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.82

0.13

4.6

6.0

mg/l

28.1

21.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

109

1.15

0.13

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

104

0.84

0.13

1.2

5.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

104

0.84

0.13

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

106

0.82

0.13

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

402

0.94

0.12

1.9

2.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

101

1013

0.96

0.12

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

241

1.08

0.11

1.5

2.9

5.1

0.51

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.16

0.11

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

215

2128

0.98

0.11

1.7

1.8

nmol/l

39.6

39.5

0.02

210

2069

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.15

0.10

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

192

1818

1.02

0.09

1.1

u/ml

7.3

6.7

0.05

249

(3010937) Rubella virus Ab [Presence] in Serum

1.08

0.09

1.0

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.08

0.09

1.0

u/ml

0.3

—

(3028707) Methadone [Presence] in Urine by Screen method

184

1742

1.02

0.09

2.3

3.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.03

0.09

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

386

1.05

0.09

1.8

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

796

1.03

0.09

1.6

1.8

—

(4198724)

482

1.04

0.08

1.4

2.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

219

0.93

0.08

1.7

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

516

5046

0.99

0.08

2.3

2.2

nmol/l

12.1

12.7

0.92

462

4468

(3045683) HLA typing for celiac disease panel - Blood or Tissue

426

0.95

0.08

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.02

0.08

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.04

0.08

1.4

1.1

u/ml

0.6

2.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.82

0.07

1.3

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

208

1.07

0.07

1.2

1.5

pmol/l

14.5

14.7

0.07

177

(3006462) Nitrate [Presence] in Urine

246

1.06

0.07

4.0

3.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

601

0.97

0.07

1.1

1.2

u/ml

4.2

10.8

0.77

272

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.03

0.07

3.3

3.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.86

0.06

4.6

6.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

180

1713

1.02

0.06

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

885

8616

0.99

0.06

1.3

1.2

u/ml

8.0

10.8

0.70

329

3372

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

411

3937

1.01

0.06

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

540

0.97

0.06

1.2

2.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

165

1622

0.98

0.06

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

353

0.96

0.05

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

323

0.96

0.05

6.9

6.7

—

(3005033) Fetal Nuchal fold Thickness US

165

1618

0.99

0.05

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

136

1335

0.99

0.04

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

132

1296

0.99

0.04

1.3

—

(3025577) Chromium [Mass/volume] in Blood

253

0.96

0.04

2.2

2.0

ug/l

2.6

2.0

0.52

216

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

409

0.97

0.04

2.7

2.9

—

23.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

625

1.02

0.04

1.2

u/ml

1.9

3.6

1.04

308

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

223

0.95

0.04

1.0

1.1

—

(44813793)

510

1.02

0.03

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

524

0.98

0.03

1.0

1.1

u/ml

0.4

1.5

—

117

(3048879) Bone marrow aspiration report

124

0.94

0.03

1.8

2.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

280

0.97

0.02

1.1

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

378

1.02

0.02

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

173

1661

1.01

0.02

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

123

0.94

0.02

1.5

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

123

0.94

0.02

1.5

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

123

0.94

0.02

1.5

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

123

0.94

0.02

1.5

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

177

1.04

0.01

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

264

1.03

0.01

1.7

1.9

ug/min

31.9

209.2

—

(3022689) Creatine [Moles/volume] in Urine

161

0.96

0.01

1.7

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

365

3534

1.00

0.00

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

201

1.01

0.00

2.8

4.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

162

1.02

0.00

1.1

—

234.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

221

1.01

0.00

2.4

2.3

mmol/l

1.1

1.9

1.17

168

(3045142) Bone marrow Pathology biopsy report

605

1.01

0.00

1.4

—

(4211845)

270

1.00

0.00

4.5

3.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

133

1.02

0.00

1.2

1.4

27.7

36.2

—

(3035933) Granulocytes/100 leukocytes in Blood

332

0.99

0.00

1.2

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

124

1.01

0.00

6.0

3.6

u/l

29.8

93.7

—

(3028717) Thiamine [Mass/volume] in Blood

0.97

0.00

1.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.97

0.00

1.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.5

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

16.0

—

(3002022) Protein C Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.2

—

57.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

2.5

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.6

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.92

0.00

1.7

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

11.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.99

0.00

2.2

2.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_VACTREL and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_VACTREL	1.843 [1.61, 2.11]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.35

During the follow-up period (1.1.1998 — 31.12.2019), 2154 out of 35509 females with Q17_VACTREL died.

Males

Parameter	HR [95% CI]	p-value
Q17_VACTREL	1.799 [1.59, 2.04]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 2437 out of 36505 males with Q17_VACTREL died.

Mortality risk

Mortality risk for people of age

years, who have Q17_VACTREL.

N-year risk	Females	Males
1	0.144%	0.293%
5	0.99%	1.807%
10	2.513%	4.776%
15	5.101%	8.982%
20	9.001%	15.397%

Relationships between endpoints

↥

Index endpoint: Q17_VACTREL – Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints